<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="molmed"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC2276142/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genome-wide association scan identifies candidate polymorphisms
associated with differential response to anti-TNF treatment in Rheumatoid
Arthritis</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276142/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Molecular Medicine"><meta name="citation_title" content="Genome-wide association scan identifies candidate polymorphisms
associated with differential response to anti-TNF treatment in Rheumatoid
Arthritis"><meta name="citation_authors" content="Chunyu Liu, Franak Batliwalla, Wentian Li, Annette Lee, Ronenn Roubenoff, Evan Beckman, Houman Khalili, Aarti Damle, Marlena Kern, Robert M. Plenge, Marieke Coenen, Timothy W. Behrens, Richard Furie, John P. Carulli, Peter K. Gregersen"><meta name="citation_date" content="Sep-Oct 2008"><meta name="citation_issue" content="9-10"><meta name="citation_volume" content="14"><meta name="citation_firstpage" content="575"><meta name="citation_doi" content="10.2119/2008-00056.Liu"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2276142/?report=abstract"><meta name="citation_pmid" content="18615156"><meta name="DC.Title" content="Genome-wide association scan identifies candidate polymorphisms
associated with differential response to anti-TNF treatment in Rheumatoid
Arthritis"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="The Feinstein Institute for Medical Research"><meta name="DC.Contributor" content="Chunyu Liu"><meta name="DC.Contributor" content="Franak Batliwalla"><meta name="DC.Contributor" content="Wentian Li"><meta name="DC.Contributor" content="Annette Lee"><meta name="DC.Contributor" content="Ronenn Roubenoff"><meta name="DC.Contributor" content="Evan Beckman"><meta name="DC.Contributor" content="Houman Khalili"><meta name="DC.Contributor" content="Aarti Damle"><meta name="DC.Contributor" content="Marlena Kern"><meta name="DC.Contributor" content="Robert M. Plenge"><meta name="DC.Contributor" content="Marieke Coenen"><meta name="DC.Contributor" content="Timothy W. Behrens"><meta name="DC.Contributor" content="Richard Furie"><meta name="DC.Contributor" content="John P. Carulli"><meta name="DC.Contributor" content="Peter K. Gregersen"><meta name="DC.Date" content="Sep-Oct 2008"><meta name="DC.Identifier" content="10.2119/2008-00056.Liu"><meta name="DC.Language" content="en"><meta property="og:title" content="Genome-wide association scan identifies candidate polymorphisms
associated with differential response to anti-TNF treatment in Rheumatoid
Arthritis"><meta property="og:type" content="article"><meta property="og:description" content="The prediction of response (or non-response) to anti-TNF treatment for Rheumatoid
Arthritis is a pressing clinical problem. We conducted a genome wide association
study using the Illumina HapMap300 SNP chip on 89 RA patients prospectively
followed after ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276142/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-molmed.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2276142/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2276142/pdf/mol-14-9-0561.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE89FE20DD3FA0910000000006EB0428.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style><style type="text/css">.MathJax_Display {text-align: center; margin: 1em 0em; position: relative; display: block!important; text-indent: 0; max-width: none; max-height: none; min-width: 0; min-height: 0; width: 100%}
.MathJax .merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}
.MathJax .MJX-monospace {font-family: monospace}
.MathJax .MJX-sans-serif {font-family: sans-serif}
#MathJax_Tooltip {background-color: InfoBackground; color: InfoText; border: 1px solid black; box-shadow: 2px 2px 5px #AAAAAA; -webkit-box-shadow: 2px 2px 5px #AAAAAA; -moz-box-shadow: 2px 2px 5px #AAAAAA; -khtml-box-shadow: 2px 2px 5px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true'); padding: 3px 4px; z-index: 401; position: absolute; left: 0; top: 0; width: auto; height: auto; display: none}
.MathJax {display: inline; font-style: normal; font-weight: normal; line-height: normal; font-size: 100%; font-size-adjust: none; text-indent: 0; text-align: left; text-transform: none; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; direction: ltr; max-width: none; max-height: none; min-width: 0; min-height: 0; border: 0; padding: 0; margin: 0}
.MathJax:focus, body :focus .MathJax {display: inline-table}
.MathJax img, .MathJax nobr, .MathJax a {border: 0; padding: 0; margin: 0; max-width: none; max-height: none; min-width: 0; min-height: 0; vertical-align: 0; line-height: normal; text-decoration: none}
img.MathJax_strut {border: 0!important; padding: 0!important; margin: 0!important; vertical-align: 0!important}
.MathJax span {display: inline; position: static; border: 0; padding: 0; margin: 0; vertical-align: 0; line-height: normal; text-decoration: none}
.MathJax nobr {white-space: nowrap!important}
.MathJax img {display: inline!important; float: none!important}
.MathJax * {transition: none; -webkit-transition: none; -moz-transition: none; -ms-transition: none; -o-transition: none}
.MathJax_Processing {visibility: hidden; position: fixed; width: 0; height: 0; overflow: hidden}
.MathJax_Processed {display: none!important}
.MathJax_ExBox {display: block!important; overflow: hidden; width: 1px; height: 60ex; min-height: 0; max-height: none}
.MathJax .MathJax_EmBox {display: block!important; overflow: hidden; width: 1px; height: 60em; min-height: 0; max-height: none}
.MathJax .MathJax_HitBox {cursor: text; background: white; opacity: 0; filter: alpha(opacity=0)}
.MathJax .MathJax_HitBox * {filter: none; opacity: 1; background: transparent}
#MathJax_Tooltip * {filter: none; opacity: 1; background: transparent}
@font-face {font-family: MathJax_Main; src: url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/woff/MathJax_Main-Regular.woff?rev=2.6.1') format('woff'), url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/otf/MathJax_Main-Regular.otf?rev=2.6.1') format('opentype')}
@font-face {font-family: MathJax_Main; src: url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/woff/MathJax_Main-Bold.woff?rev=2.6.1') format('woff'), url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/otf/MathJax_Main-Bold.otf?rev=2.6.1') format('opentype'); font-weight: bold}
@font-face {font-family: MathJax_Main; src: url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/woff/MathJax_Main-Italic.woff?rev=2.6.1') format('woff'), url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/otf/MathJax_Main-Italic.otf?rev=2.6.1') format('opentype'); font-style: italic}
@font-face {font-family: MathJax_Math; src: url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/woff/MathJax_Math-Italic.woff?rev=2.6.1') format('woff'), url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/otf/MathJax_Math-Italic.otf?rev=2.6.1') format('opentype'); font-style: italic}
@font-face {font-family: MathJax_Caligraphic; src: url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/woff/MathJax_Caligraphic-Regular.woff?rev=2.6.1') format('woff'), url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/otf/MathJax_Caligraphic-Regular.otf?rev=2.6.1') format('opentype')}
@font-face {font-family: MathJax_Size1; src: url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/woff/MathJax_Size1-Regular.woff?rev=2.6.1') format('woff'), url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/otf/MathJax_Size1-Regular.otf?rev=2.6.1') format('opentype')}
@font-face {font-family: MathJax_Size2; src: url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/woff/MathJax_Size2-Regular.woff?rev=2.6.1') format('woff'), url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/otf/MathJax_Size2-Regular.otf?rev=2.6.1') format('opentype')}
@font-face {font-family: MathJax_Size3; src: url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/woff/MathJax_Size3-Regular.woff?rev=2.6.1') format('woff'), url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/otf/MathJax_Size3-Regular.otf?rev=2.6.1') format('opentype')}
@font-face {font-family: MathJax_Size4; src: url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/woff/MathJax_Size4-Regular.woff?rev=2.6.1') format('woff'), url('https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/fonts/HTML-CSS/TeX/otf/MathJax_Size4-Regular.otf?rev=2.6.1') format('opentype')}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div style="visibility: hidden; overflow: hidden; position: absolute; top: 0px; height: 1px; width: auto; padding: 0px; border: 0px none; margin: 0px; text-align: left; text-indent: 0px; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal;"><div id="MathJax_Hidden"></div></div><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2276142%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed">PubMed</option><option value="books">Books</option><option value="nlmcatalog" class="last">NLM Catalog</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/325/">Mol Med</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/171726/">v.14(9-10); Sep-Oct 2008</a></li><li class="accid">PMC2276142</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-molmed.png" alt="Logo of molmed" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://molmed.biomedcentral.com/" target="pmc_ext" ref="reftype=publisher&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Mol Med</a></span>. 2008 Sep-Oct; 14(9-10): 575–581. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Jul 10. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.2119%2F2008-00056.Liu" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.2119/2008-00056.Liu</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2276142</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18615156">18615156</a></div></div></div></div><h1 class="content-title">Genome-wide association scan identifies candidate polymorphisms
associated with differential response to anti-TNF treatment in Rheumatoid
Arthritis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Liu%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677539245872" co-class="co-affbox">Chunyu Liu</a>,<sup>1</sup> <a href="/pubmed/?term=Batliwalla%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677460552432" co-class="co-affbox">Franak Batliwalla</a>,<sup>2</sup> <a href="/pubmed/?term=Li%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677457078944" co-class="co-affbox">Wentian Li</a>,<sup>2</sup> <a href="/pubmed/?term=Lee%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677457076960" co-class="co-affbox">Annette Lee</a>,<sup>2</sup> <a href="/pubmed/?term=Roubenoff%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677460698480" co-class="co-affbox">Ronenn Roubenoff</a>,<sup>1</sup> <a href="/pubmed/?term=Beckman%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677463600560" co-class="co-affbox">Evan Beckman</a>,<sup>1</sup> <a href="/pubmed/?term=Khalili%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677463598576" co-class="co-affbox">Houman Khalili</a>,<sup>2</sup> <a href="/pubmed/?term=Damle%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677538907568" co-class="co-affbox">Aarti Damle</a>,<sup>2</sup> <a href="/pubmed/?term=Kern%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677460346128" co-class="co-affbox">Marlena Kern</a>,<sup>2</sup> <a href="/pubmed/?term=Plenge%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677460344144" co-class="co-affbox">Robert M. Plenge</a>,<sup>2</sup> <a href="/pubmed/?term=Coenen%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677468538064" co-class="co-affbox">Marieke Coenen</a>,<sup>4</sup> <a href="/pubmed/?term=Behrens%20TW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677467723680" co-class="co-affbox">Timothy W. Behrens</a>,<sup>5</sup> <a href="/pubmed/?term=Furie%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677467721696" co-class="co-affbox">Richard Furie</a>,<sup>6</sup> <a href="/pubmed/?term=Carulli%20JP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677460968608" co-class="co-affbox">John P. Carulli</a>,<sup>1</sup> and  <a href="/pubmed/?term=Gregersen%20PK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156" class="affpopup" co-rid="_co_idm140677539080128" co-class="co-affbox">Peter K. Gregersen</a><sup>2</sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140677539245872"><h3 class="no_margin">Chunyu Liu</h3><p>  <sup>1</sup> Biogen Idec, Inc., Cambridge, Mass.</p><div>Find articles by <a href="/pubmed/?term=Liu%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Chunyu Liu</a></div></div><div id="_co_idm140677460552432"><h3 class="no_margin">Franak Batliwalla</h3><p>  <sup>2</sup> The Feinstein Institute for Medical Research, North Shore L.I.J. Health System, Manhasset, N.Y.</p><div>Find articles by <a href="/pubmed/?term=Batliwalla%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Franak Batliwalla</a></div></div><div id="_co_idm140677457078944"><h3 class="no_margin">Wentian Li</h3><p>  <sup>2</sup> The Feinstein Institute for Medical Research, North Shore L.I.J. Health System, Manhasset, N.Y.</p><div>Find articles by <a href="/pubmed/?term=Li%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Wentian Li</a></div></div><div id="_co_idm140677457076960"><h3 class="no_margin">Annette Lee</h3><p>  <sup>2</sup> The Feinstein Institute for Medical Research, North Shore L.I.J. Health System, Manhasset, N.Y.</p><div>Find articles by <a href="/pubmed/?term=Lee%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Annette Lee</a></div></div><div id="_co_idm140677460698480"><h3 class="no_margin">Ronenn Roubenoff</h3><p>  <sup>1</sup> Biogen Idec, Inc., Cambridge, Mass.</p><div>Find articles by <a href="/pubmed/?term=Roubenoff%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Ronenn Roubenoff</a></div></div><div id="_co_idm140677463600560"><h3 class="no_margin">Evan Beckman</h3><p>  <sup>1</sup> Biogen Idec, Inc., Cambridge, Mass.</p><div>Find articles by <a href="/pubmed/?term=Beckman%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Evan Beckman</a></div></div><div id="_co_idm140677463598576"><h3 class="no_margin">Houman Khalili</h3><p>  <sup>2</sup> The Feinstein Institute for Medical Research, North Shore L.I.J. Health System, Manhasset, N.Y.</p><div>Find articles by <a href="/pubmed/?term=Khalili%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Houman Khalili</a></div></div><div id="_co_idm140677538907568"><h3 class="no_margin">Aarti Damle</h3><p>  <sup>2</sup> The Feinstein Institute for Medical Research, North Shore L.I.J. Health System, Manhasset, N.Y.</p><div>Find articles by <a href="/pubmed/?term=Damle%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Aarti Damle</a></div></div><div id="_co_idm140677460346128"><h3 class="no_margin">Marlena Kern</h3><p>  <sup>2</sup> The Feinstein Institute for Medical Research, North Shore L.I.J. Health System, Manhasset, N.Y.</p><div>Find articles by <a href="/pubmed/?term=Kern%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Marlena Kern</a></div></div><div id="_co_idm140677460344144"><h3 class="no_margin">Robert M. Plenge</h3><p>  <sup>2</sup> The Feinstein Institute for Medical Research, North Shore L.I.J. Health System, Manhasset, N.Y.</p><div>Find articles by <a href="/pubmed/?term=Plenge%20RM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Robert M. Plenge</a></div></div><div id="_co_idm140677468538064"><h3 class="no_margin">Marieke Coenen</h3><p>  <sup>4</sup> Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands</p><div>Find articles by <a href="/pubmed/?term=Coenen%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Marieke Coenen</a></div></div><div id="_co_idm140677467723680"><h3 class="no_margin">Timothy W. Behrens</h3><p>  <sup>5</sup> Genentech Inc., South San Francisco, CA, 94080, USA</p><div>Find articles by <a href="/pubmed/?term=Behrens%20TW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Timothy W. Behrens</a></div></div><div id="_co_idm140677467721696"><h3 class="no_margin">Richard Furie</h3><p>  <sup>6</sup> Division of Rheumatology/Immunology/Allergy, North Shore L.I.J. Health System, Manhasset, N.Y</p><div>Find articles by <a href="/pubmed/?term=Furie%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Richard Furie</a></div></div><div id="_co_idm140677460968608"><h3 class="no_margin">John P. Carulli</h3><p>  <sup>1</sup> Biogen Idec, Inc., Cambridge, Mass.</p><div>Find articles by <a href="/pubmed/?term=Carulli%20JP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">John P. Carulli</a></div></div><div id="_co_idm140677539080128"><h3 class="no_margin">Peter K. Gregersen</h3><p>  <sup>2</sup> The Feinstein Institute for Medical Research, North Shore L.I.J. Health System, Manhasset, N.Y.</p><div>Find articles by <a href="/pubmed/?term=Gregersen%20PK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18615156">Peter K. Gregersen</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140677469132672_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140677469132672_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140677469132672_ai" style="display:none"><div class="fm-affl" id="af1-08_56_liu" lang="en">  <sup>1</sup> Biogen Idec, Inc., Cambridge, Mass.</div><div class="fm-affl" id="af2-08_56_liu" lang="en">  <sup>2</sup> The Feinstein Institute for Medical Research, North Shore L.I.J. Health System, Manhasset, N.Y.</div><div class="fm-affl" id="af3-08_56_liu" lang="en">  <sup>3</sup> The Broad Institute of Harvard and the Massachusetts Institute of Technology, Cambridge, Mass</div><div class="fm-affl" id="af4-08_56_liu" lang="en">  <sup>4</sup> Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands</div><div class="fm-affl" id="af5-08_56_liu" lang="en">  <sup>5</sup> Genentech Inc., South San Francisco, CA, 94080, USA</div><div class="fm-affl" id="af6-08_56_liu" lang="en">  <sup>6</sup> Division of Rheumatology/Immunology/Allergy, North Shore L.I.J. Health System, Manhasset, N.Y</div><div id="c1-08_56_Liu">Correspondence can be addressed to Dr. Gregersen: Peter K. Gregersen MD, Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, North Shore LIJ Health System, 350 Community Drive, Manhasset, New York, 11030 <a href="mailto:dev@null" data-email="ude.shsn@gretep" class="oemail">ude.shsn@gretep</a>, telephone: 516-562-1542</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140677469132672_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2276142/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div><a href="/pmc/articles/PMC2276142/bin/08_56_Liu_Suppl.pdf" data-ga-action="click_feat_suppl">08_56_Liu_Suppl.pdf</a><span style="color:gray"> (88K)</span></div><div class="small guid">GUID:&nbsp;5D80C9AF-174F-4282-B236-07E371C6E2DA</div></div></dd></dl></div><div id="idm140677446103952" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140677446103952title">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first-last">The prediction of response (or non-response) to anti-TNF treatment for Rheumatoid
Arthritis is a pressing clinical problem. We conducted a genome wide association
study using the Illumina HapMap300 SNP chip on 89 RA patients prospectively
followed after beginning anti-TNF therapy as part of Autoimmune Biomarkers
Collaborative Network (ABCoN) patient cohort. Response to therapy was determined
by the change in Disease Activity Score (DAS28) observed after 14 weeks. We used
a two part analysis that treated the change in DAS28 as a continuous trait and
then incorporated into a dichotomous trait of “good responder”
and “nonresponder” by EULAR criteria. We corrected for multiple
tests by permutation, and adjusted for potential population stratification using
Eigenstrat. Multiple SNP markers showed significant associations near or within
loci including the v-maf musculoaponeurotic fibrosarcoma oncogene homolog B
(MAFB) gene on chromosome 20, the type I interferon gene IFNk on chromosome 9,
and in a locus on chromosome 7 that includes the paraoxonase I (PON1) gene A SNP
in the IL10 promoter (rs1800896) that was previously reported as associated with
anti-TNF response was weakly associated with response in this cohort.
Replications of these results in independent and larger data sets are clearly
required. We provide a reference list of candidate SNPs (p&lt;0.01) that can be
investigated in future pharmacogenomic studies.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Tumor Necrosis Factor, Rheumatoid arthritis, Genome Wide Association, Pharmacogenetics</span></div></div><div id="__sec1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title">Introduction</h2><p id="__p2" class="p p-first">Tumor necrosis factor – alpha (TNF-α) is a key regulator of the
inflammatory cascade in rheumatoid arthritis (RA) and several other inflammatory
diseases(<a href="#b1-08_56_liu" rid="b1-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712421" role="button" aria-expanded="false" aria-haspopup="true">1</a>–<a href="#b3-08_56_liu" rid="b3-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712402" role="button" aria-expanded="false" aria-haspopup="true">3</a>). To date, three TNF antagonists,
Infliximab (Remicade), Etanercept (Enbrel) and Adalimumab (Humira), have been
approved by the FDA to treat rheumatoid arthritis and other inflammatory diseases.
The molecular mechanisms for these three TNF inhibitors are similar: they block the
binding of TNF-α to its cell-surface receptors and limit subsequent cell
signaling pathways that are induced or regulated by TNF-α. Etanercept is a
dimeric TNF receptor-IgG fusion protein and mimics the inhibition effects of soluble
TNF receptor by binding to TNF-α. Infliximab is a chimeric mouse-human
antibody, while Adalimumab is a fully humanized antibody.</p><p id="__p3">Although the therapeutic utility of TNF-α antagonism is well established,
patients display substantial heterogeneity in their response to anti-TNF therapies,
and the efficacy of any anti-TNF agent in a given patient is unpredictable.
Approximately one third of patients have minimal or no response to these agents
(<a href="#b4-08_56_liu" rid="b4-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712383" role="button" aria-expanded="false" aria-haspopup="true">4</a>). A genetic influence has
been suggested based on candidate gene studies(<a href="#b5-08_56_liu" rid="b5-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712410" role="button" aria-expanded="false" aria-haspopup="true">5</a>, <a href="#b6-08_56_liu" rid="b6-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712392" role="button" aria-expanded="false" aria-haspopup="true">6</a>),
but no comprehensive analysis of this issue has been reported. In a recent review,
Coenen et al (<a href="#b7-08_56_liu" rid="b7-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712393" role="button" aria-expanded="false" aria-haspopup="true">7</a>) summarized 17
pharmacogenetic studies of anti-TNF treatment that were conducted after 2001. All of
the 17 studies focused on polymorphisms in genes known to be involved in RA
pathogenesis, genes encoding TNF-α receptors, or genes implicated in
TNF-α metabolism. Several groups reported that a single nucleotide
polymorphism (SNP), -308G&gt;A, in the promoter of TNFA is significantly associated
with the outcome to anti-TNF treatment (<a href="#b5-08_56_liu" rid="b5-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712418" role="button" aria-expanded="false" aria-haspopup="true">5</a>, <a href="#b8-08_56_liu" rid="b8-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712397" role="button" aria-expanded="false" aria-haspopup="true">8</a>–<a href="#b14-08_56_liu" rid="b14-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712422" role="button" aria-expanded="false" aria-haspopup="true">14</a>). This positive association is
also supported by a meta-analysis that was performed using 311 patients combined
from several studies (<a href="#b13-08_56_liu" rid="b13-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712387" role="button" aria-expanded="false" aria-haspopup="true">13</a>).</p><p id="__p4" class="p p-last">In order to identify biomarkers influencing response to anti-TNF therapy, the
Autoimmune Biomarkers Collaborative Network (ABCoN) has prospectively enrolled
cohort of Rheumatoid Arthritis patients beginning anti-TNF treatment. Using these
patient samples, we took an unbiased genome wide approach to finding common genetic
variations that could be responsible for individual differences in response to the
three anti-TNF agents. We report results for SNPs with lowest p-values from the GWA
study, and provide details for selected candidate genes.</p></div><div id="__sec2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec2title">Methods</h2><div id="__sec3" class="sec sec-first"><p></p><h3 id="__sec3title" class="inline">Patients </h3><p id="__p5" class="p p-first-last">The Autoimmune Biomarkers Collaborative Network (ABCoN) was established in order
to explore the use of new technologies for biomarker discovery in both RA and
Systemic Lupus (SLE). The ABCoN Rheumatoid Arthritis cohort includes 116 active
RA patients followed prospectively to evaluate efficacy of the three available
anti-TNF agents. In order to examine the response to anti-TNF therapy in RA,
blood samples, laboratory and clinical data were collected at baseline (prior to
anti-TNF therapy), 6 weeks, 3 months, 6 months and 1-year post treatment. DNA,
RNA, peripheral blood cells, plasma, serum and urine were obtained at the time
of each study visit. Enrollment criteria included having a minimum of six
swollen joints at enrollment, and no previous exposure to anti-TNF agents during
the six months prior to enrollment in the study. We did not enroll patients
taking more than 10 mg of oral steroid therapy per day at the time of
enrollment. All the patients provided written informed consent. The study
protocols were approved by local ethics committees.</p></div><div id="__sec4" class="sec"><p></p><h3 id="__sec4title" class="inline">Efficacy measurements </h3><p id="__p6" class="p p-first">Disease severity was evaluated using the DAS28 score which is the Disease
Activity Score that includes 28-joint counts and C-reactive protein(<a href="#b15-08_56_liu" rid="b15-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712396" role="button" aria-expanded="false" aria-haspopup="true">15</a>). DAS28 was measured at three
time points: baseline, 6 weeks, and 14 weeks. Two scales were considered to
evaluate efficacy of anti-TNF treatment. First, a relative improvement in
disease activity was calculated for each patient using the DAS28 scores at
baseline and at week 14:</p><div class="disp-formula"><div class="f"><span class="MathJax_Preview"></span><div class="MathJax_Display" style="text-align: center;"><span class="MathJax" id="MathJax-Element-1-Frame" tabindex="0" style=""><nobr><span class="math" id="mml1" overflow="scroll" role="math" style="width: 26.141em; display: inline-block;"><span style="display: inline-block; position: relative; width: 21.591em; height: 0px; font-size: 121%;"><span style="position: absolute; clip: rect(1.856em, 1021.51em, 4.565em, -1000em); top: -3.461em; left: 0em;"><span class="mrow" id="MathJax-Span-2"><span class="mrow" id="MathJax-Span-3"><span class="mrow" id="MathJax-Span-4"><span class="mi" id="MathJax-Span-5" style="font-family: MathJax_Math; font-style: italic;">r</span><span class="mi" id="MathJax-Span-6" style="font-family: MathJax_Math; font-style: italic;">e</span><span class="mi" id="MathJax-Span-7" style="font-family: MathJax_Math; font-style: italic;">l</span><span class="mi" id="MathJax-Span-8" style="font-family: MathJax_Math; font-style: italic;">D</span><span class="mi" id="MathJax-Span-9" style="font-family: MathJax_Math; font-style: italic;">A</span><span class="mi" id="MathJax-Span-10" style="font-family: MathJax_Math; font-style: italic;">S<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.032em;"></span></span><span class="mn" id="MathJax-Span-11" style="font-family: MathJax_Main;">28</span><span class="mo" id="MathJax-Span-12" style="font-family: MathJax_Main; padding-left: 0.278em;">=</span><span class="mrow" id="MathJax-Span-13" style="padding-left: 0.278em;"><span class="mo" id="MathJax-Span-14" style="vertical-align: 0em;"><span style="font-family: MathJax_Size3;">(</span></span><span class="mrow" id="MathJax-Span-15"><span class="mfrac" id="MathJax-Span-16"><span style="display: inline-block; position: relative; width: 12.798em; height: 0px; margin-right: 0.12em; margin-left: 0.12em;"><span style="position: absolute; clip: rect(3.106em, 1012.64em, 4.154em, -1000em); top: -4.654em; left: 50%; margin-left: -6.339em;"><span class="mrow" id="MathJax-Span-17"><span class="mi" id="MathJax-Span-18" style="font-family: MathJax_Math; font-style: italic;">D</span><span class="mi" id="MathJax-Span-19" style="font-family: MathJax_Math; font-style: italic;">A</span><span class="mi" id="MathJax-Span-20" style="font-family: MathJax_Math; font-style: italic;">S<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.032em;"></span></span><span class="mn" id="MathJax-Span-21" style="font-family: MathJax_Main;">28</span><span class="mi" id="MathJax-Span-22" style="font-family: MathJax_Math; font-style: italic;">v</span><span class="mi" id="MathJax-Span-23" style="font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-24" style="font-family: MathJax_Math; font-style: italic;">s</span><span class="mi" id="MathJax-Span-25" style="font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-26" style="font-family: MathJax_Math; font-style: italic;">t</span><span class="mn" id="MathJax-Span-27" style="font-family: MathJax_Main;">1</span><span class="mo" id="MathJax-Span-28" style="font-family: MathJax_Main; padding-left: 0.222em;">−</span><span class="mi" id="MathJax-Span-29" style="font-family: MathJax_Math; font-style: italic; padding-left: 0.222em;">D</span><span class="mi" id="MathJax-Span-30" style="font-family: MathJax_Math; font-style: italic;">A</span><span class="mi" id="MathJax-Span-31" style="font-family: MathJax_Math; font-style: italic;">S<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.032em;"></span></span><span class="mn" id="MathJax-Span-32" style="font-family: MathJax_Main;">28</span><span class="mi" id="MathJax-Span-33" style="font-family: MathJax_Math; font-style: italic;">v</span><span class="mi" id="MathJax-Span-34" style="font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-35" style="font-family: MathJax_Math; font-style: italic;">s</span><span class="mi" id="MathJax-Span-36" style="font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-37" style="font-family: MathJax_Math; font-style: italic;">t</span><span class="mn" id="MathJax-Span-38" style="font-family: MathJax_Main;">3</span></span><span style="display: inline-block; width: 0px; height: 3.977em;"></span></span><span style="position: absolute; clip: rect(3.106em, 1005.66em, 4.154em, -1000em); top: -3.291em; left: 50%; margin-left: -2.864em;"><span class="mrow" id="MathJax-Span-39"><span class="mi" id="MathJax-Span-40" style="font-family: MathJax_Math; font-style: italic;">D</span><span class="mi" id="MathJax-Span-41" style="font-family: MathJax_Math; font-style: italic;">A</span><span class="mi" id="MathJax-Span-42" style="font-family: MathJax_Math; font-style: italic;">S<span style="display: inline-block; overflow: hidden; height: 1px; width: 0.032em;"></span></span><span class="mn" id="MathJax-Span-43" style="font-family: MathJax_Main;">28</span><span class="mi" id="MathJax-Span-44" style="font-family: MathJax_Math; font-style: italic;">v</span><span class="mi" id="MathJax-Span-45" style="font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-46" style="font-family: MathJax_Math; font-style: italic;">s</span><span class="mi" id="MathJax-Span-47" style="font-family: MathJax_Math; font-style: italic;">i</span><span class="mi" id="MathJax-Span-48" style="font-family: MathJax_Math; font-style: italic;">t</span><span class="mn" id="MathJax-Span-49" style="font-family: MathJax_Main;">1</span></span><span style="display: inline-block; width: 0px; height: 3.977em;"></span></span><span style="position: absolute; clip: rect(0.865em, 1012.8em, 1.24em, -1000em); top: -1.305em; left: 0em;"><span style="display: inline-block; overflow: hidden; vertical-align: 0em; border-top: 1.3px solid; width: 12.798em; height: 0px;"></span><span style="display: inline-block; width: 0px; height: 1.085em;"></span></span></span></span></span><span class="mo" id="MathJax-Span-50" style="vertical-align: 0em;"><span style="font-family: MathJax_Size3;">)</span></span></span><span class="mo" id="MathJax-Span-51" style="font-family: MathJax_Main; padding-left: 0.167em;">%</span><span class="mo" id="MathJax-Span-52" style="font-family: MathJax_Main;">.</span></span></span></span><span style="display: inline-block; width: 0px; height: 3.461em;"></span></span></span><span style="display: inline-block; overflow: hidden; vertical-align: -1.211em; border-left: 0px solid; width: 0px; height: 3.028em;"></span></span></nobr></span></div><script type="math/mml" id="MathJax-Element-1"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="block" id="mml1" overflow="scroll"><mrow><mrow><mi>r</mi><mi>e</mi><mi>l</mi><mi>D</mi><mi>A</mi><mi>S</mi><mn>28</mn><mo>=</mo><mrow><mo>(</mo><mrow><mfrac><mrow><mi>D</mi><mi>A</mi><mi>S</mi><mn>28</mn><mi>v</mi><mi>i</mi><mi>s</mi><mi>i</mi><mi>t</mi><mn>1</mn><mo>-</mo><mi>D</mi><mi>A</mi><mi>S</mi><mn>28</mn><mi>v</mi><mi>i</mi><mi>s</mi><mi>i</mi><mi>t</mi><mn>3</mn></mrow><mrow><mi>D</mi><mi>A</mi><mi>S</mi><mn>28</mn><mi>v</mi><mi>i</mi><mi>s</mi><mi>i</mi><mi>t</mi><mn>1</mn></mrow></mfrac></mrow><mo>)</mo></mrow><mo>%</mo><mo>.</mo></mrow></mrow></math></script></div></div><p id="__p7" class="p p-last"><em>RelDAS</em>28 has a continuous scale and is approximately normal.
Second, according to the EULAR definition published elsewhere (<a href="#b16-08_56_liu" rid="b16-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712407" role="button" aria-expanded="false" aria-haspopup="true">16</a>), patients are classified as
good, moderate or non-responders, using the individual amount of change in the
DAS28 (ΔDAS28) and DAS28 values at 14 weeks (<a href="#b16-08_56_liu" rid="b16-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712379" role="button" aria-expanded="false" aria-haspopup="true">16</a>). Briefly, a good responder is classified if
ΔDAS28 1.2 and DAS28 at 14 weeks 3.2; a moderate responders are patients
with (ΔDAS28 1.2 and DAS28 at 14 weeks &gt; 3.2) or (0.6
&lt;ΔDAS28 1.2 and DAS28 at 14 weeks 5.1). Patients are classified as
non-responders if they do not fall into any of these categories (<a href="#b16-08_56_liu" rid="b16-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712390" role="button" aria-expanded="false" aria-haspopup="true">16</a>).</p></div><div id="__sec5" class="sec"><p></p><h3 id="__sec5title" class="inline">Genotyping and quality control </h3><p id="__p8" class="p p-first">The patients’ genomic DNA was extracted from peripheral blood using
standard protocols. We genotyped 317,000 Single Nucleotide Polymorphisms (SNPs)
on 102 anti-TNF treated patients using an Illumina Beadstation and Illumina
HAP300 chips according to the Illumina Infinium 2 assay manual (Illumina), as
previously described (<a href="#b17-08_56_liu" rid="b17-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712414" role="button" aria-expanded="false" aria-haspopup="true">17</a>). The
HAP300 chip includes, on average, a SNP every 10 kilobases across all the
autosomes, and interrogates approximately 87% of the common genetic
variation in populations of European descent (<a href="#b18-08_56_liu" rid="b18-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712413" role="button" aria-expanded="false" aria-haspopup="true">18</a>).</p><p id="__p9" class="p p-last">To ensure SNP marker quality and reduce the possibility of false associations,
quality control procedures were performed on each of the 317k SNPs before
association tests were carried out. The SNP set was filtered on the basis of
genotype call rates ( 95%), minor allele frequency (MAF 0.05).
Hardy–Weinberg equilibrium (HWE) was calculated for individual SNPs
using the Exact test. All of the SNPs reported in this manuscript have HWE
p-values &gt; 0.001. After filtering, 283,348 polymorphic SNPs were analyzed on
chromosome 1 through chromosome 22. The average call rate for the filtered SNPs
was 99.5%. We removed patients if their percentage of missing genotypes
was more than 5% or if there was evidence of possible contamination in
their DNA sample.</p></div><div id="__sec6" class="sec sec-last"><p></p><h3 id="__sec6title" class="inline">Statistical analysis </h3><p id="__p10" class="p p-first">We evaluated associations between SNP markers and response to the anti-TNF
therapies in two stages. In the first stage of our analysis, we used
<em>relDAS</em>28 as a continuous dependent variable to evaluate the
associations. Because the sample size is relatively small in our study, a
continuous scale of the dependent variable has more power than a categorized
variable. Linear regression was carried out to evaluate association between
individual SNP markers and response to anti-TNF therapies (i.e.,
<em>relDAS</em>28) in the context of additive genetic effect model.
A t- statistic was derived from regression and used to evaluate association
between individual SNP markers and response to anti-TNF therapies (i.e.,
<em>relDAS</em>28). The t-statistic is robust, and thus some
departure from normality for the dependent variable is acceptable. Because more
than 283,348 tests were involved in this study, a permutation test was carried
out to account for multiple testing on each chromosome. The permutation test can
also address the slight deviation from normality in the dependent variable. To
obtain adjusted p-values, the phenotypic values were randomly shuffled to break
the relationship between phenotype and genotype. The entire analysis was
repeated on the shuffled data; therefore, the shuffled data is representative of
the null hypothesis. The 1,000 smallest p-values were obtained from each of the
N = 1,000 permutation iterations for the whole set of SNPs on individual
chromosomes.</p><p id="__p11">In the second stage analysis, we use a categorized dependent variable –
response status to the anti-TNF therapy (i.e., non-responders vs. good
responders) to evaluate association with SNPs selected from the first stage. The
probability of being a non-responder was modeled using logistic regression with
additive genetic effect model. Unless specified, all calculations for
statistical analysis were carried out using the R software package (Version
2.2.1).</p><p id="__p12" class="p p-last">Population admixture (i.e., sampling of subjects from two or more subpopulations)
has been recognized as a major cause for inconsistent results and spurious
associations for genetic studies(<a href="#b19-08_56_liu" rid="b19-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712381" role="button" aria-expanded="false" aria-haspopup="true">19</a>, <a href="#b20-08_56_liu" rid="b20-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712409" role="button" aria-expanded="false" aria-haspopup="true">20</a>). U.S.
populations are genetically admixed. Although self-reported ethnicity data was
recorded in this study, it is incomplete and may be inaccurate. To accurately
classify individuals according to ancestry and to remove any possible related
individuals, we calculated pair-wise identity-by-state (IBS) distance for the
102 subjects and performed subsequent complete linkage agglomerative clustering
and multidimensional scaling using genome-wide SNP markers in Plink software
(version 1.00, <a href="http://pngu.mgh.harvard.edu/~purcell/plink/index.shtml" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://pngu.mgh.harvard.edu/~purcell/plink/index.shtml</a>).
Clustering data were plotted to identify major population subdivisions. In
addition to removing outliers from the dataset, we further evaluated potential
effect from subpopulations (e.g. northern and southern Europeans) by the
EIGENSTRAT program with genome wide SNP data (<a href="#b21-08_56_liu" rid="b21-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712386" role="button" aria-expanded="false" aria-haspopup="true">21</a>). The top ten principal components (PCs) were
obtained. Correlation analysis between the top PCs and the phenotypes
(<em>delDAS</em>28 and dichotomous response status to anti-TNF) was
performed to detect if the phenotypic difference among individuals were due to
population stratification. If the spread of samples in these principal
components was purely due to population stratification, it can be removed by
forcing all samples to have zero value in these principal components. Then a
"virtual" genotype can be obtained by rotating the corrected principal
components back to the original genotype space. Pearson's chi-square test
was performed for association between selected SNPs and response status to the
anti-TNF therapy (i.e., non-responders vs. good responders)</p></div></div><div id="__sec7" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec7title">Results</h2><p id="__p13" class="p p-first">Among the 102 active RA patients with complete genotypic and phenotypic data,
self-reported ancestry included 83 Europeans, four Asians, three American Africans,
as well as three subjects with reported Latino ethnicity. Nine patients have missing
information for their ethnicity. Linkage agglomerative clustering and
multidimensional scaling identified 89 patients with primarily European ancestry
(Supplementary <a href="#SD1" rid="SD1" class=" supplementary-material">Fig. 1</a>),
among them 83 was self-reported to be white and 6 had missing ethnicity data. These
89 patients were used for subsequent association analysis.</p><p id="__p14" class="p">The baseline characteristics of the 89 patients are summarized in <a href="/pmc/articles/PMC2276142/table/t1-08_56_liu/" target="table" class="fig-table-link figpopup" rid-figpopup="t1-08_56_liu" rid-ob="ob-t1-08_56_liu" co-legend-rid=""><span>Table 1</span></a>. At the time of diagnosis,
they were 47±14 (mean ± S.D) yr old, their disease duration was
8±9 years, 75% were women, and 15% were current smokers, and
the average serum CRP level (mg/dl) at baseline was 1.7 (S.D. = 2.0). On
average, the DAS28 at the baseline (before anti-TNF therapy) was 5.22 (S.D.
= 0.80), indicating that the RA disease activity was high for most of the
patients(<a href="#b16-08_56_liu" rid="b16-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712408" role="button" aria-expanded="false" aria-haspopup="true">16</a>). 54 subjects were
treated with Etanercept, 37 with Infliximab, and 25 with Adalimumab. These patients
had a mean disease duration of 8 years; 46% had been previously treated with
other DMARDs, and seven patients had been previously treated with TNF
inhibitors.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="t1-08_56_liu"><h3>Table 1</h3><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140677436992832" class="xtable"><table frame="box" rules="groups" class="rendered small default_table"><thead><tr><th colspan="2" rowspan="1" align="center">Patient Characteristics: European descent
(n=89)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">Age (yr)</td><td rowspan="1" colspan="1" align="center">57+13.5</td></tr><tr><td rowspan="1" colspan="1" align="left">Age at diagnosis (yr)</td><td rowspan="1" colspan="1" align="center">47 ± 15</td></tr><tr><td rowspan="1" colspan="1" align="left">Women: (%)</td><td rowspan="1" colspan="1" align="center">75</td></tr><tr><td rowspan="1" colspan="1" align="left">Disease duration (yr)</td><td rowspan="1" colspan="1" align="center">8 ± 8</td></tr><tr><td rowspan="1" colspan="1" align="left">Current Smokers (%)</td><td rowspan="1" colspan="1" align="center">15</td></tr><tr><td rowspan="1" colspan="1" align="left">Pain VAS</td><td rowspan="1" colspan="1" align="center">50.0 ± 22.3</td></tr><tr><td rowspan="1" colspan="1" align="left">Health VAS</td><td rowspan="1" colspan="1" align="center">46.4 ± 17.5</td></tr><tr><td rowspan="1" colspan="1" align="left">Tender (no.)</td><td rowspan="1" colspan="1" align="center">11.8 ± 6.2</td></tr><tr><td rowspan="1" colspan="1" align="left">Swollen (no.)</td><td rowspan="1" colspan="1" align="center">11.2 ± 4.8</td></tr><tr><td rowspan="1" colspan="1" align="left">HAQ</td><td rowspan="1" colspan="1" align="center">1.13 ± 0.61</td></tr><tr><td rowspan="1" colspan="1" align="left">Physician’s global assessment</td><td rowspan="1" colspan="1" align="center">49.4 ± 19.0</td></tr><tr><td rowspan="1" colspan="1" align="left">RF at baseline</td><td rowspan="1" colspan="1" align="center">238.2 ± 369.6</td></tr><tr><td rowspan="1" colspan="1" align="left">RF+ %</td><td rowspan="1" colspan="1" align="center">83.75%<sup>*</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">Serum CRP level (mg/dl) at baseline</td><td rowspan="1" colspan="1" align="center">1.7 ± 2.0</td></tr><tr><td rowspan="1" colspan="1" align="left">CCP+ %</td><td rowspan="1" colspan="1" align="center">61.9%<sup>**</sup></td></tr><tr><td rowspan="1" colspan="1" align="left">DAS 28 at baseline</td><td rowspan="1" colspan="1" align="center">5.22 ± 0.80</td></tr><tr><td rowspan="1" colspan="1" align="left">DAS 28 at 6 weeks</td><td rowspan="1" colspan="1" align="center">3.99 ± 1.13</td></tr><tr><td rowspan="1" colspan="1" align="left">DAS 28 at 14 weeks</td><td rowspan="1" colspan="1" align="center">3.72 ± 1.32</td></tr><tr><td colspan="2" rowspan="1" align="left"><span class="underline">anti-TNF drug</span></td></tr><tr><td rowspan="1" colspan="1" align="left"> Enbrel</td><td rowspan="1" colspan="1" align="center">n = 39</td></tr><tr><td rowspan="1" colspan="1" align="left"> Humira</td><td rowspan="1" colspan="1" align="center">n = 18</td></tr><tr><td rowspan="1" colspan="1" align="left"> Remicade</td><td rowspan="1" colspan="1" align="center">n = 32</td></tr><tr><td colspan="2" rowspan="1" align="left"><span class="underline">Other
Medication</span></td></tr><tr><td rowspan="1" colspan="1" align="left"> Steroids</td><td rowspan="1" colspan="1" align="center">63%</td></tr><tr><td rowspan="1" colspan="1" align="left"> Methotrexate</td><td rowspan="1" colspan="1" align="center">63%</td></tr><tr><td rowspan="1" colspan="1" align="left"> DMARDS</td><td rowspan="1" colspan="1" align="center">46%</td></tr><tr><td rowspan="1" colspan="1" align="left">   Arava</td><td rowspan="1" colspan="1" align="center">n = 16</td></tr><tr><td rowspan="1" colspan="1" align="left">   Azathioprine</td><td rowspan="1" colspan="1" align="center">n = 1</td></tr><tr><td rowspan="1" colspan="1" align="left">   Sulfasalazine</td><td rowspan="1" colspan="1" align="center">n = 18</td></tr><tr><td rowspan="1" colspan="1" align="left">   Plaquenil</td><td rowspan="1" colspan="1" align="center">n = 15</td></tr></tbody></table></div><div id="largeobj_idm140677436992832" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2276142/table/t1-08_56_liu/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="tfn1-08_56_liu"><sup>*</sup>11 subjects missing RF data</div><div id="tfn2-08_56_liu"><sup>**</sup>5 subjects missing CCP data</div></div></div><div id="__sec8" class="sec"><p></p><h3 id="__sec8title" class="inline">Genome-wide association studies: 1<sup>st</sup> stage analysis </h3><p id="__p15" class="p p-first">The GWA analyses were performed to test for association between 283,348
polymorphic SNPs and the relative change in DAS28 (<em>relDAS</em>28)
using an additive genetic model. We did not further adjust the principal
components in our regression model, because they did not significantly correlate
with <em>relDAS</em>28 (i.e. the major phenotypic difference among
individuals was not due to population stratification) (Supplementary <a href="#SD1" rid="SD1" class=" supplementary-material">Table 1</a>). The chromosomal
distribution of p-values for the genome wide association is shown in <a href="/pmc/articles/PMC2276142/figure/f1-08_56_liu/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1-08_56_liu" rid-ob="ob-f1-08_56_liu" co-legend-rid="lgnd_f1-08_56_liu"><span>Fig. 1</span></a>. To address multiple testing
issues, a chromosome-wide permutation test was performed. Sixteen SNPs remain
significant (permutation exact p 0.05) or borderline significant (0.05 &lt;
permutation exact p 0.1) after permutation test to obtain exact significance
levels. The p-values along with annotation information for these 16 SNPs are
shown in <a href="/pmc/articles/PMC2276142/table/t2-08_56_liu/" target="table" class="fig-table-link figpopup" rid-figpopup="t2-08_56_liu" rid-ob="ob-t2-08_56_liu" co-legend-rid=""><span>Table 2</span></a>. Among these
sixteen SNPs, four are located within genes, one is in the 3’UTR, and
eleven are in the flanking regions of genes. All these SNPs are common
polymorphisms (minor allele frequency &gt; 0.1). In addition to <a href="/pmc/articles/PMC2276142/table/t2-08_56_liu/" target="table" class="fig-table-link figpopup" rid-figpopup="t2-08_56_liu" rid-ob="ob-t2-08_56_liu" co-legend-rid=""><span>Table 2</span></a>, we also provide data for
2985 SNPs with <em>relDAS</em>28 p-values 0.01 in Supplementary <a href="#SD1" rid="SD1" class=" supplementary-material">Table 1</a>. We used the
Illumina annotation file “HumanHap317K_geneannotation.txt”
together with the UCSC Genome Browser to annotate SNP details (<a href="#b22-08_56_liu" rid="b22-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712411" role="button" aria-expanded="false" aria-haspopup="true">22</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="f1-08_56_liu" co-legend-rid="lgnd_f1-08_56_liu"><a href="/pmc/articles/PMC2276142/figure/f1-08_56_liu/" target="figure" rid-figpopup="f1-08_56_liu" rid-ob="ob-f1-08_56_liu"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140677463368144" class="figure"><a href="/pmc/articles/PMC2276142/figure/f1-08_56_liu/" target="figure" rid-figpopup="f1-08_56_liu" rid-ob="ob-f1-08_56_liu"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2536555_mol-14-9-0561f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is mol-14-9-0561f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2276142/bin/mol-14-9-0561f1.jpg"></a></div><div id="largeobj_idm140677463368144" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2276142/figure/f1-08_56_liu/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_f1-08_56_liu"><div><a class="figpopup" href="/pmc/articles/PMC2276142/figure/f1-08_56_liu/" target="figure" rid-figpopup="f1-08_56_liu" rid-ob="ob-f1-08_56_liu">Fig. 1</a></div><!--caption a7--><div class="caption"><p id="__p29">Genome wide association p-value plots showing the association of
single-nucleotide polymorphism (SNPs) with relative change in DAS28 score
(<em>relDAS</em>28). Chromosomal location is shown on the
abscissa. P values shown on the ordinate are uncorrected.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="t2-08_56_liu"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p32">Sixteen SNPs with smallest p-values with permutation exact p-values 0.1</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140677460220176" class="xtable"><table frame="void" rules="none" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1" align="left">SNP</th><th rowspan="1" colspan="1" align="center">P-value<sup>1</sup> of <em>RelDAS</em>28</th><th rowspan="1" colspan="1" align="center">Permut. p-value (<em>RelDAS</em>28)</th><th rowspan="1" colspan="1" align="center">Polymorphism</th><th rowspan="1" colspan="1" align="center">Allele associated with non-response (Allele
Frequency)</th><th rowspan="1" colspan="1" align="center">Chr</th><th rowspan="1" colspan="1" align="center">Physical position</th><th rowspan="1" colspan="1" align="center">Known Genes</th><th rowspan="1" colspan="1" align="center">Location<sup>3</sup></th><th rowspan="1" colspan="1" align="center">P-value<sup>2</sup> Non-responders vs. Good responders (Adjusted)<sup>4</sup></th><th rowspan="1" colspan="1" align="center">Odds Ratio (OR) being non-responder (95% CI)
<sup>2</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" align="left">rs983332</td><td rowspan="1" colspan="1" align="left">0.000005</td><td rowspan="1" colspan="1" align="center">0.008</td><td rowspan="1" colspan="1" align="center">A/C</td><td rowspan="1" colspan="1" align="center">A (0.21)</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="left">87844401</td><td rowspan="1" colspan="1" align="center">LMO4</td><td rowspan="1" colspan="1" align="center">F3U</td><td rowspan="1" colspan="1" align="left">0.00007 (0.00009)</td><td rowspan="1" colspan="1" align="left">10.2 (2.6, 59.2)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs928655</td><td rowspan="1" colspan="1" align="left">0.00003</td><td rowspan="1" colspan="1" align="center">0.07</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">A (0.77)</td><td rowspan="1" colspan="1" align="center">1</td><td rowspan="1" colspan="1" align="left">89561595</td><td rowspan="1" colspan="1" align="center">GBP6</td><td rowspan="1" colspan="1" align="center">I</td><td rowspan="1" colspan="1" align="left">0.0009 (0.0004)</td><td rowspan="1" colspan="1" align="left">5.5 (1.8, 20.2)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs13393173</td><td rowspan="1" colspan="1" align="left">0.000004</td><td rowspan="1" colspan="1" align="center">0.02</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">A (0.12)</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="left">169214598</td><td rowspan="1" colspan="1" align="center">LASS6</td><td rowspan="1" colspan="1" align="center">I</td><td rowspan="1" colspan="1" align="left">0.004 (0.02)</td><td rowspan="1" colspan="1" align="left">6.8 (1.7, 40.3)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs437943</td><td rowspan="1" colspan="1" align="left">0.000004</td><td rowspan="1" colspan="1" align="center">0.1</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">G (0.33)</td><td rowspan="1" colspan="1" align="center">4</td><td rowspan="1" colspan="1" align="left">35194664</td><td rowspan="1" colspan="1" align="center">CENTD1</td><td rowspan="1" colspan="1" align="center">F3U</td><td rowspan="1" colspan="1" align="left">0.0007 (0.002)</td><td rowspan="1" colspan="1" align="left">4.6 (1.8, 12.3)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs10945919</td><td rowspan="1" colspan="1" align="left">0.0000003</td><td rowspan="1" colspan="1" align="center">0.004</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">G (0.32)</td><td rowspan="1" colspan="1" align="center">6</td><td rowspan="1" colspan="1" align="left">164157088</td><td rowspan="1" colspan="1" align="center">QKI</td><td rowspan="1" colspan="1" align="center">F3U</td><td rowspan="1" colspan="1" align="left">0.0007 (0.0008)</td><td rowspan="1" colspan="1" align="left">4.6 (1.8, 12.3)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs854555</td><td rowspan="1" colspan="1" align="left">0.000002</td><td rowspan="1" colspan="1" align="center">0.03</td><td rowspan="1" colspan="1" align="center">A/C</td><td rowspan="1" colspan="1" align="center">A (0.34)</td><td rowspan="1" colspan="1" align="center">7</td><td rowspan="1" colspan="1" align="left">94575042</td><td rowspan="1" colspan="1" align="center">PON1</td><td rowspan="1" colspan="1" align="center">I</td><td rowspan="1" colspan="1" align="left">0.0006 (0.001)</td><td rowspan="1" colspan="1" align="left">4.6 (1.8, 12.3)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs854548</td><td rowspan="1" colspan="1" align="left">0.000003</td><td rowspan="1" colspan="1" align="center">0.06</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">A (0.27)</td><td rowspan="1" colspan="1" align="center">7</td><td rowspan="1" colspan="1" align="left">94570471</td><td rowspan="1" colspan="1" align="center">PON1</td><td rowspan="1" colspan="1" align="center">F3U</td><td rowspan="1" colspan="1" align="left">0.00004 (0.0003)</td><td rowspan="1" colspan="1" align="left">8.5 (2.6, 36.5)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs854547</td><td rowspan="1" colspan="1" align="left">0.000006</td><td rowspan="1" colspan="1" align="center">0.1</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">A (0.63)</td><td rowspan="1" colspan="1" align="center">7</td><td rowspan="1" colspan="1" align="left">94568507</td><td rowspan="1" colspan="1" align="center">PON1</td><td rowspan="1" colspan="1" align="center">F3U</td><td rowspan="1" colspan="1" align="left">0.003 (0.004)</td><td rowspan="1" colspan="1" align="left">3.6 (1.5, 9.3)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs7046653</td><td rowspan="1" colspan="1" align="left">0.0000005</td><td rowspan="1" colspan="1" align="center">0.01</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">A (0.26)</td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="left">27480967</td><td rowspan="1" colspan="1" align="center">IFNK</td><td rowspan="1" colspan="1" align="center">F5U</td><td rowspan="1" colspan="1" align="left">0.0004 (0.002)</td><td rowspan="1" colspan="1" align="left">4.9 (1.8, 14.0)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs868856</td><td rowspan="1" colspan="1" align="left">0.0000005</td><td rowspan="1" colspan="1" align="center">0.01</td><td rowspan="1" colspan="1" align="center">C/T</td><td rowspan="1" colspan="1" align="center">T (0.26)</td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="left">27479251</td><td rowspan="1" colspan="1" align="center">MOBKL2B</td><td rowspan="1" colspan="1" align="center">I</td><td rowspan="1" colspan="1" align="left">0.0005 (0.002)</td><td rowspan="1" colspan="1" align="left">4.9 (1.8, 14.0)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs774359</td><td rowspan="1" colspan="1" align="left">0.0000006</td><td rowspan="1" colspan="1" align="center">0.01</td><td rowspan="1" colspan="1" align="center">C/T</td><td rowspan="1" colspan="1" align="center">C (0.22)</td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="left">27551049</td><td rowspan="1" colspan="1" align="center">C9orf72</td><td rowspan="1" colspan="1" align="center">3UTR</td><td rowspan="1" colspan="1" align="left">0.0005 (0.005)</td><td rowspan="1" colspan="1" align="left">5.4 (1.9, 17.3)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs2814707</td><td rowspan="1" colspan="1" align="left">0.000002</td><td rowspan="1" colspan="1" align="center">0.04</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">A (0.22)</td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="left">27526397</td><td rowspan="1" colspan="1" align="center">MOBKL2B</td><td rowspan="1" colspan="1" align="center">F5U</td><td rowspan="1" colspan="1" align="left">0.0006 (0.007)</td><td rowspan="1" colspan="1" align="left">5.2 (1.8, 16.7)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs3849942</td><td rowspan="1" colspan="1" align="left">0.000005</td><td rowspan="1" colspan="1" align="center">0.07</td><td rowspan="1" colspan="1" align="center">A/G</td><td rowspan="1" colspan="1" align="center">A (0.21)</td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="left">27533281</td><td rowspan="1" colspan="1" align="center">C9orf72</td><td rowspan="1" colspan="1" align="center">F3U</td><td rowspan="1" colspan="1" align="left">0.001 (0.01)</td><td rowspan="1" colspan="1" align="left">5.0 (1.7, 15.8)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs6028945</td><td rowspan="1" colspan="1" align="left">0.0000002</td><td rowspan="1" colspan="1" align="center">0.003</td><td rowspan="1" colspan="1" align="center">G/T</td><td rowspan="1" colspan="1" align="center">T (0.12)</td><td rowspan="1" colspan="1" align="center">20</td><td rowspan="1" colspan="1" align="left">38254219</td><td rowspan="1" colspan="1" align="center">MAFB</td><td rowspan="1" colspan="1" align="center">F3U</td><td rowspan="1" colspan="1" align="left">0.0004 (0.006)</td><td rowspan="1" colspan="1" align="left">11.2 (2.3, 108.1)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs6138150</td><td rowspan="1" colspan="1" align="left">0.000003</td><td rowspan="1" colspan="1" align="center">0.05</td><td rowspan="1" colspan="1" align="center">C/T</td><td rowspan="1" colspan="1" align="center">T (0.84)</td><td rowspan="1" colspan="1" align="center">20</td><td rowspan="1" colspan="1" align="left">23795009</td><td rowspan="1" colspan="1" align="center">CST5</td><td rowspan="1" colspan="1" align="center">F3U</td><td rowspan="1" colspan="1" align="left">0.0002 (0.002)</td><td rowspan="1" colspan="1" align="left">11.1 (2.5, 103.3)</td></tr><tr><td rowspan="1" colspan="1" align="left">rs6071980</td><td rowspan="1" colspan="1" align="left">0.000003</td><td rowspan="1" colspan="1" align="center">0.05</td><td rowspan="1" colspan="1" align="center">C/T</td><td rowspan="1" colspan="1" align="center">C (0.13)</td><td rowspan="1" colspan="1" align="center">20</td><td rowspan="1" colspan="1" align="left">38301990</td><td rowspan="1" colspan="1" align="center">MAFB</td><td rowspan="1" colspan="1" align="center">F3U</td><td rowspan="1" colspan="1" align="left">0.0009 (0.01)</td><td rowspan="1" colspan="1" align="left">7.6 (1.9, 44.6)</td></tr></tbody></table></div><div id="largeobj_idm140677460220176" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC2276142/table/t2-08_56_liu/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="tfn3-08_56_liu"><sup>1</sup>Note: These p-values were obtained using the continuous
<em>relDAS</em>28 as a dependent variable;</div><div id="tfn4-08_56_liu"><sup>2</sup>These p-values or Odds Ratios (95% CI) were obtained from Fisher
exact test of 2x2 tables of allele frequencies in non-responders vs.
good responders;</div><div id="tfn5-08_56_liu"><sup>3</sup>F3U: flanking 3’-UTR; F5U: flanking 5’-UTR; I: intron; C:
coding; 3UTR: 3’-UTR;</div><div id="tfn6-08_56_liu"><sup>4</sup>Chi-square p-values after adjusting for population substructure in
EIGENSTRAT.</div></div></div><p id="__p16" class="p p-last">Among these leading associations, the rs6028945 marker ~500Kb 3’ of the
MAFB locus on chromosome 20 is marginally the strongest association
(p=0.003 corrected) when the relative change in DAS28 is considered as a
continuous variable; a second marker in the region of MAFB, rs6071980 also shows
evidence of association (p=0.05, corrected). Likewise, multimarker
evidence of association is seen with markers in the Paraoxinase 1 gene (PON1) as
well as in a region of chromosome 9 that contains the interferon kappa (IFNK),
MOBKL2B and C9orf72 loci. Other loci showing some evidence of association
include a guanylate nucleotide binding protein (GBP6) at 1p22.2, LAG1 (longevity
assurance homolog 6, LASS6) at chr2, cystatin D (CST5) at 20p11.21, centaurin,
delta 1 (CENTD1) at 4p14, quaking homolog, and KH domain RNA binding (QK1) at
6q26-q27 (<a href="/pmc/articles/PMC2276142/table/t2-08_56_liu/" target="table" class="fig-table-link figpopup" rid-figpopup="t2-08_56_liu" rid-ob="ob-t2-08_56_liu" co-legend-rid=""><span>Table 2</span></a>).</p></div><div id="__sec9" class="sec"><p></p><h3 id="__sec9title" class="inline">Association between SNPs and response to anti-TNF therapy: 2<sup>nd</sup>
stage analysis </h3><p id="__p17" class="p p-first-last">According to the criteria of EULAR( <a href="#b16-08_56_liu" rid="b16-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712401" role="button" aria-expanded="false" aria-haspopup="true">16</a>), the 89 patients under study can be categorized into three
groups: 23 non-responders, 31 good responders and 35 moderate responders using
the baseline DAS28 and the change in DAS28 at 14 weeks. We compared allele
frequencies between non-responders and good responders using the
Fisher’s exact test (<a href="#b23-08_56_liu" rid="b23-08_56_liu" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">23</a>). The last two columns of <a href="/pmc/articles/PMC2276142/table/t2-08_56_liu/" target="table" class="fig-table-link figpopup" rid-figpopup="t2-08_56_liu" rid-ob="ob-t2-08_56_liu" co-legend-rid=""><span>Table 2</span></a> display Fishers exact p-values and Odds Ratios (ORs) with
95% confidence intervals (CIs) for the non-responder status to the
anti-TNF therapies. Note that these 95% CIs are very wide, reflecting
the small sample size (i.e. 23 non-responders vs. 31 good-responders) in this
study. The major principal components did not appear to predict good responder
vs. nonresponder status (Supplementary <a href="#SD1" rid="SD1" class=" supplementary-material">Fig. 2</a>). Because the sample size is quite small (23
non-responders vs. 31 responders), a minor effect due to subpopulation may have
large impact on the 2X2 table estimate. Therefore, we further adjusted
subpopulation structure to give adjusted Chi-square p-values using EIGENSTRAT.
As shown in <a href="/pmc/articles/PMC2276142/table/t2-08_56_liu/" target="table" class="fig-table-link figpopup" rid-figpopup="t2-08_56_liu" rid-ob="ob-t2-08_56_liu" co-legend-rid=""><span>Table 2</span></a>, these
adjusted Chi-square p-values are generally larger than the Fisher’s
exact test p-values.</p></div><div id="__sec10" class="sec sec-last"><p></p><h3 id="__sec10title" class="inline">SNPs in candidate genes </h3><p id="__p18" class="p p-first-last">Of the markers present on the Illumina HapMap 300 chip, four SNP associations
with TNF response have been reported previously in candidate gene studies:
rs1800896 in IL10 (<a href="#b8-08_56_liu" rid="b8-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712391" role="button" aria-expanded="false" aria-haspopup="true">8</a>, <a href="#b24-08_56_liu" rid="b24-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712400" role="button" aria-expanded="false" aria-haspopup="true">24</a>), rs419598 in interleukin 1
receptor antagonist (IL1RN) (<a href="#b14-08_56_liu" rid="b14-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712420" role="button" aria-expanded="false" aria-haspopup="true">14</a>), rs1041981 in LTA(<a href="#b25-08_56_liu" rid="b25-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712388" role="button" aria-expanded="false" aria-haspopup="true">25</a>–<a href="#b27-08_56_liu" rid="b27-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712417" role="button" aria-expanded="false" aria-haspopup="true">27</a>), and
rs4149570 in TNFRSF1A(<a href="#b26-08_56_liu" rid="b26-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712385" role="button" aria-expanded="false" aria-haspopup="true">26</a>).
These markers were evaluated separately in view of their increased prior
probability. In the current study, only rs1800896 shows evidence of association,
with a p-value of 0.0132 (uncorrected) with the <em>delDAS</em>28 and
0.0183 (corrected for stratification only) with responding status to anti-TNF
therapy.</p></div></div><div id="__sec11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec11title">Discussion</h2><p id="__p19" class="p p-first">In this report, we describe the first genome-wide association study to evaluate
pharmacogenetic effects on the response to anti-TNF treatment for rheumatoid
arthritis. Several SNPs show significant association with the change in DAS28
observed in these patients over a 14-week period of treatment.</p><p id="__p20">Two SNPs located approximately 500kb downstream of the MAFB (v-maf musculoaponeurotic
fibrosarcoma oncogene homolog B) locus show significant evidence of association
after correction by permutation and after accounting for the possible effects of
population stratification. This gene is a member of the Maf family of bZIP
transcription factors that are generally involved in cellular differentiation(<a href="#b28-08_56_liu" rid="b28-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712395" role="button" aria-expanded="false" aria-haspopup="true">28</a>). MAFB is a putative tumor
suppressor in the myeloid lineage, with a key role in monopoiesis(<a href="#b29-08_56_liu" rid="b29-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712382" role="button" aria-expanded="false" aria-haspopup="true">29</a>) as well as monocytedendritic cell
differentiation(<a href="#b30-08_56_liu" rid="b30-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712398" role="button" aria-expanded="false" aria-haspopup="true">30</a>). Little is
known about the biology of this gene in the context of inflammatory disease.</p><p id="__p21">Another interesting association with anti-TNF response was found in the paraoxonase
(PON1) locus. Paraoxonase is an enzyme associated with high density lipoproteins
that may play a role in inflammatory disease(<a href="#b31-08_56_liu" rid="b31-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712415" role="button" aria-expanded="false" aria-haspopup="true">31</a>). Low serum levels of PON1 have been reported in
inflammatory disorders (<a href="#b32-08_56_liu" rid="b32-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712419" role="button" aria-expanded="false" aria-haspopup="true">32</a>, <a href="#b33-08_56_liu" rid="b33-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712384" role="button" aria-expanded="false" aria-haspopup="true">33</a>), including rheumatoid
arthritis(<a href="#b34-08_56_liu" rid="b34-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712389" role="button" aria-expanded="false" aria-haspopup="true">34</a>), although in the
setting of autoimmunity, most attention as been on the anti-inflammatory effects of
PON1 in risk for cardiovascular disease(<a href="#b35-08_56_liu" rid="b35-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712399" role="button" aria-expanded="false" aria-haspopup="true">35</a>). Genetic regulation of Paraoxonase 1 levels has been
documented(<a href="#b36-08_56_liu" rid="b36-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712427" role="button" aria-expanded="false" aria-haspopup="true">36</a>, <a href="#b37-08_56_liu" rid="b37-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712394" role="button" aria-expanded="false" aria-haspopup="true">37</a>), although not always by
polymorphisms within PON1 (<a href="#b38-08_56_liu" rid="b38-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712416" role="button" aria-expanded="false" aria-haspopup="true">38</a>).
TNF-α, IL6 and PON1 levels appear to be correlated in the setting of
rheumatoid arthritis(<a href="#b39-08_56_liu" rid="b39-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712405" role="button" aria-expanded="false" aria-haspopup="true">39</a>), although
it is certainly not clear why genetic variation in PON1 should influence response to
TNF inhibition.</p><p id="__p22">Five SNPs in a region of chromosome 9 across a 70kb region also showed association
with treatment response. Of the three genes in this region with high LD,
IFNκ is the most compelling candidate for involvement in inflammation and/or
response to anti-TNF treatment, since type I IFNs clearly play a role in
inflammatory disease(<a href="#b40-08_56_liu" rid="b40-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712423" role="button" aria-expanded="false" aria-haspopup="true">40</a>).</p><p id="__p23">Only 4 specific SNPs previously tested for association with anti-TNF treatment were
included on the 317K chip. Of these, we found that the G allele of rs1800896
(flanking region of IL10) is associated with good response to anti-TNF therapies (OR
= 2.7 (95%CI: 1.2~6.7), Fisher’s p = 0.0183), which
is consistent with previous result that the combination of GG at this locus was
associated with good response to etanercept (<a href="#b8-08_56_liu" rid="b8-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712404" role="button" aria-expanded="false" aria-haspopup="true">8</a>). One SNP reported to be associated with response to
anti-TNF treatment is rs1800629, located in the promoter of the TNF-α gene
(<a href="#b7-08_56_liu" rid="b7-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712426" role="button" aria-expanded="false" aria-haspopup="true">7</a>). Neither this SNP nor
perfect surrogates are on the Illumina 317K array. Thus, our data cannot replicate
this previous finding.</p><p id="__p24">As with other previous reports on the pharmacogenetics of TNF response, this study is
limited by a relatively small sample size. Therefore, instead of a dichotomous
classification of patients into non-responders vs. good-responders, we first
utilized the continuous score of the relative change in DAS28 (i.e.,
<em>delDAS</em>28) as the dependent variable in a regression model, so
that we were able utilize all subjects and therefore maximize the statistical power
of the study. We also performed chromosome-wide permutation tests to address the
issue of multiple testing. Bonferroni adjustments are often used in adjusting
statistical significance for multiple tests. However, the Bonferroni test is highly
conservative, particularly in the way it tests the overall null hypothesis, i.e. all
null hypotheses are true simultaneously (<a href="#b41-08_56_liu" rid="b41-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712412" role="button" aria-expanded="false" aria-haspopup="true">41</a>). Furthermore, Bonferroni assumes all tests are independent, and
since there is linkage disequilibrium among some of the SNPs on the 317K chip the
tests are not truly independent. Finally, in addition to analyzing the change in
DAS28 as a continuous trait, we classified the patients into 3 response groups (i.e.
non-, moderate, and good responders) and analyzed association to anti-TNF response
using the two extreme groups. The Fisher’s exact p-values for the
dichotomous trait are consistent with the <em>relDAS</em>28 p-values in most
circumstances (i.e. smaller Fisher’s exact p-values are consistent with
smaller <em>relDAS</em>28 p-values).</p><p id="__p25">In addition to carefully choosing the analytical approach in this analysis, we
thoroughly investigated sub-population structure in our study subjects to reduce
false positive association that might be caused by population admixture (<a href="#b19-08_56_liu" rid="b19-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712425" role="button" aria-expanded="false" aria-haspopup="true">19</a>, <a href="#b20-08_56_liu" rid="b20-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712424" role="button" aria-expanded="false" aria-haspopup="true">20</a>). We calculated IBS estimation and further
performed agglomerative clustering analysis using the PLINK software to detect
population admixture and strata. We selected 89 subjects with predominantly European
ancestry and performed subsequently statistical analyses using only these subjects.
Furthermore, we performed principal component analysis using the EIGENSTRAT software
to detect possible minor phenotypic difference in individuals due to any
subpopulation structure and provided adjusted Chi-square p-values for selected SNPs
in this report.</p><p id="__p26">A further caution regarding these results relates to the fact that our population was
rather diverse clinically, with some patients having quite longstanding disease and
nearly 40% of the patients were CCP antibody negative. Seven of the 89
patients had previously been treated with a TNF inhibitor. Therefore, this
population is clearly not representative of a new onset cohort, where information
about TNF responsiveness might be most clinically useful. Clearly, replications of
these results in independent and much larger data sets are required to confirm these
findings. Given the fact that so many patients have been treated with these agents
over the last decade, it is disappointing that these population resources are not
readily available. Nevertheless, several European RA cohorts may be useful for such
replication studies (<a href="#b7-08_56_liu" rid="b7-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712406" role="button" aria-expanded="false" aria-haspopup="true">7</a>, <a href="#b42-08_56_liu" rid="b42-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712380" role="button" aria-expanded="false" aria-haspopup="true">42</a>). In addition, we and others are
actively engaged in an effort to recruit a U.S. cohort of up to 1,000 RA patients
beginning treatment with TNF inhibitors. Samples sizes of this magnitude or larger
will be required in order to provide robust replication of the current results.</p><p id="__p27" class="p p-last">A test predicting response or non-response to anti-TNF treatment would be an
important tool in the hands of physicians. TNF inhibitors are currently a mainstay
of biologic therapy in RA. However, only a fraction of patients show a clinically
meaningful response to anti-TNF treatment after 3–6 months. Furthermore,
many patients lose response over time. After patients fail their first TNF
inhibitor, physicians are faced with a choice between trying a second TNF inhibitor
or moving to a biologic therapy with a different mechanism of action(<a href="#b43-08_56_liu" rid="b43-08_56_liu" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_625712403" role="button" aria-expanded="false" aria-haspopup="true">43</a>). Additional biologic agents with
different mechanisms of action are available for RA patients who have an inadequate
response to TNF inhibitors and more potential therapies are in late phases of
clinical development. The ability to determine whether patients are likely to be a
non-responder to a TNF inhibitor would make these treatment decisions more rational.
The current results suggest that this may be achievable.</p></div><div id="__sec12" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec12title">Supplemental Data</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><div class="sup-box half_rhythm" id="idm140677460921216"><a href="/pmc/articles/PMC2276142/bin/08_56_Liu_Suppl.pdf" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(88K, pdf)</sup></div></div></div><div id="idm140677460919616" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140677460919616title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="b1-08_56_liu">1. <span class="element-citation">Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid
arthritis. <span><span class="ref-journal">Annu Rev
Immunol. </span>1996;<span class="ref-vol">14</span>:397–440.</span> [<a href="/pubmed/8717520" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev
Immunol&amp;title=Role+of+cytokines+in+rheumatoid
arthritis&amp;author=M+Feldmann&amp;author=FM+Brennan&amp;author=RN+Maini&amp;volume=14&amp;publication_year=1996&amp;pages=397-440&amp;pmid=8717520&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b2-08_56_liu">2. <span class="element-citation">Feldmann M. What is the mechanism of action
of anti-tumour necrosis factor-alpha antibody in rheumatoid
arthritis? <span><span class="ref-journal">Int Arch Allergy
Immunol. </span>1996;<span class="ref-vol">111</span>:362–365.</span> [<a href="/pubmed/8957109" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+Arch+Allergy
Immunol&amp;title=What+is+the+mechanism+of+action
of+anti-tumour+necrosis+factor-alpha+antibody+in+rheumatoid
arthritis?&amp;author=M+Feldmann&amp;volume=111&amp;publication_year=1996&amp;pages=362-365&amp;pmid=8957109&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b3-08_56_liu">3. <span class="element-citation">Saxne T, Palladino MA, Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis
factor alpha but not tumor necrosis factor beta in rheumatoid arthritis
synovial fluid and serum. <span><span class="ref-journal">Arthritis and
rheumatism. </span>1988;<span class="ref-vol">31</span>:1041–1045.</span> [<a href="/pubmed/3136775" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+and
rheumatism&amp;title=Detection+of+tumor+necrosis
factor+alpha+but+not+tumor+necrosis+factor+beta+in+rheumatoid+arthritis
synovial+fluid+and+serum&amp;author=T+Saxne&amp;author=MA+Palladino&amp;author=D+Heinegard&amp;author=N+Talal&amp;author=FA+Wollheim&amp;volume=31&amp;publication_year=1988&amp;pages=1041-1045&amp;pmid=3136775&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b4-08_56_liu">4. <span class="element-citation">Bathon JM, Martin RW, Fleischmann RM, et al.  A comparison of etanercept and
methotrexate in patients with early rheumatoid
arthritis. <span><span class="ref-journal">N Engl J
Med. </span>2000;<span class="ref-vol">343</span>:1586–1593.</span> [<a href="/pubmed/11096165" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J
Med&amp;title=A+comparison+of+etanercept+and
methotrexate+in+patients+with+early+rheumatoid
arthritis&amp;author=JM+Bathon&amp;author=RW+Martin&amp;author=RM+Fleischmann&amp;volume=343&amp;publication_year=2000&amp;pages=1586-1593&amp;pmid=11096165&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b5-08_56_liu">5. <span class="element-citation">Mugnier B, Balandraud N, Darque A, Roudier C, Roudier J, Reviron D. Polymorphism at position -308 of
the tumor necrosis factor alpha gene influences outcome of infliximab
therapy in rheumatoid arthritis. <span><span class="ref-journal">Arthritis and
rheumatism. </span>2003;<span class="ref-vol">48</span>:1849–1852.</span> [<a href="/pubmed/12847678" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+and
rheumatism&amp;title=Polymorphism+at+position+-308+of
the+tumor+necrosis+factor+alpha+gene+influences+outcome+of+infliximab
therapy+in+rheumatoid+arthritis&amp;author=B+Mugnier&amp;author=N+Balandraud&amp;author=A+Darque&amp;author=C+Roudier&amp;author=J+Roudier&amp;volume=48&amp;publication_year=2003&amp;pages=1849-1852&amp;pmid=12847678&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b6-08_56_liu">6. <span class="element-citation">Martinez A, Salido M, Bonilla G, et al.  Association of the major
histocompatibility complex with response to infliximab therapy in rheumatoid
arthritis patients. <span><span class="ref-journal">Arthritis and
rheumatism. </span>2004;<span class="ref-vol">50</span>:1077–1082.</span> [<a href="/pubmed/15077289" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+and
rheumatism&amp;title=Association+of+the+major
histocompatibility+complex+with+response+to+infliximab+therapy+in+rheumatoid
arthritis+patients&amp;author=A+Martinez&amp;author=M+Salido&amp;author=G+Bonilla&amp;volume=50&amp;publication_year=2004&amp;pages=1077-1082&amp;pmid=15077289&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b7-08_56_liu">7. <span class="element-citation">Coenen MJ, Toonen EJ, Scheffer H, Radstake TR, Barrera P, Franke B. Pharmacogenetics of anti-TNF
treatment in patients with rheumatoid
arthritis. <span><span class="ref-journal">Pharmacogenomics. </span>2007;<span class="ref-vol">8</span>:761–773.</span> [<a href="/pubmed/17638513" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics&amp;title=Pharmacogenetics+of+anti-TNF
treatment+in+patients+with+rheumatoid
arthritis&amp;author=MJ+Coenen&amp;author=EJ+Toonen&amp;author=H+Scheffer&amp;author=TR+Radstake&amp;author=P+Barrera&amp;volume=8&amp;publication_year=2007&amp;pages=761-773&amp;pmid=17638513&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b8-08_56_liu">8. <span class="element-citation">Padyukov L, Lampa J, Heimburger M, et al.  Genetic markers for the efficacy
of tumour necrosis factor blocking therapy in rheumatoid
arthritis. <span><span class="ref-journal">Ann Rheum
Dis. </span>2003;<span class="ref-vol">62</span>:526–529.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1754569/">PMC free article</a>]</span> [<a href="/pubmed/12759288" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum
Dis&amp;title=Genetic+markers+for+the+efficacy
of+tumour+necrosis+factor+blocking+therapy+in+rheumatoid
arthritis&amp;author=L+Padyukov&amp;author=J+Lampa&amp;author=M+Heimburger&amp;volume=62&amp;publication_year=2003&amp;pages=526-529&amp;pmid=12759288&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b9-08_56_liu">9. <span class="element-citation">Balog A, Klausz G, Gal J, et al.  Investigation of the prognostic
value of TNF-alpha gene polymorphism among patients treated with infliximab,
and the effects of infliximab therapy on TNF-alpha production and
apoptosis. <span><span class="ref-journal">Pathobiology. </span>2004;<span class="ref-vol">71</span>:274–280.</span> [<a href="/pubmed/15459487" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pathobiology&amp;title=Investigation+of+the+prognostic
value+of+TNF-alpha+gene+polymorphism+among+patients+treated+with+infliximab,
and+the+effects+of+infliximab+therapy+on+TNF-alpha+production+and
apoptosis&amp;author=A+Balog&amp;author=G+Klausz&amp;author=J+Gal&amp;volume=71&amp;publication_year=2004&amp;pages=274-280&amp;pmid=15459487&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b10-08_56_liu">10. <span class="element-citation">Fonseca JE, Carvalho T, Cruz M, et al.  Polymorphism at position -308 of
the tumour necrosis factor alpha gene and rheumatoid arthritis
pharmacogenetics. <span><span class="ref-journal">Ann Rheum
Dis. </span>2005;<span class="ref-vol">64</span>:793–794.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1755496/">PMC free article</a>]</span> [<a href="/pubmed/15834068" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum
Dis&amp;title=Polymorphism+at+position+-308+of
the+tumour+necrosis+factor+alpha+gene+and+rheumatoid+arthritis
pharmacogenetics&amp;author=JE+Fonseca&amp;author=T+Carvalho&amp;author=M+Cruz&amp;volume=64&amp;publication_year=2005&amp;pages=793-794&amp;pmid=15834068&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b11-08_56_liu">11. <span class="element-citation">Cuchacovich M, Soto L, Edwardes M, et al.  Tumour necrosis factor (TNF)alpha
-308 G/G promoter polymorphism and TNFalpha levels correlate with a better
response to adalimumab in patients with rheumatoid
arthritis. <span><span class="ref-journal">Scand J
Rheumatol. </span>2006;<span class="ref-vol">35</span>:435–440.</span> [<a href="/pubmed/17343250" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand+J
Rheumatol&amp;title=Tumour+necrosis+factor+(TNF)alpha
-308+G/G+promoter+polymorphism+and+TNFalpha+levels+correlate+with+a+better
response+to+adalimumab+in+patients+with+rheumatoid
arthritis&amp;author=M+Cuchacovich&amp;author=L+Soto&amp;author=M+Edwardes&amp;volume=35&amp;publication_year=2006&amp;pages=435-440&amp;pmid=17343250&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b12-08_56_liu">12. <span class="element-citation">Seitz M, Wirthmuller U, Moller B, Villiger PM. The -308 tumour necrosis
factor-alpha gene polymorphism predicts therapeutic response to
TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis
patients. <span><span class="ref-journal">Rheumatology
(Oxford) </span>2007;<span class="ref-vol">46</span>:93–96.</span> [<a href="/pubmed/16720636" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology
(Oxford)&amp;title=The+-308+tumour+necrosis
factor-alpha+gene+polymorphism+predicts+therapeutic+response+to
TNFalpha-blockers+in+rheumatoid+arthritis+and+spondyloarthritis
patients&amp;author=M+Seitz&amp;author=U+Wirthmuller&amp;author=B+Moller&amp;author=PM+Villiger&amp;volume=46&amp;publication_year=2007&amp;pages=93-96&amp;pmid=16720636&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b13-08_56_liu">13. <span class="element-citation">Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. Association of TNF-alpha -308 G/A
polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid
arthritis: a meta-analysis. <span><span class="ref-journal">Rheumatol
Int. </span>2006;<span class="ref-vol">27</span>:157–161.</span> [<a href="/pubmed/16909270" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatol
Int&amp;title=Association+of+TNF-alpha+-308+G/A
polymorphism+with+responsiveness+to+TNF-alpha-blockers+in+rheumatoid
arthritis:+a+meta-analysis&amp;author=YH+Lee&amp;author=YH+Rho&amp;author=SJ+Choi&amp;author=JD+Ji&amp;author=GG+Song&amp;volume=27&amp;publication_year=2006&amp;pages=157-161&amp;pmid=16909270&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b14-08_56_liu">14. <span class="element-citation">Marotte H, Pallot-Prades B, Grange L, et al.  The shared epitope is a marker of
severity associated with selection for, but not with response to, infliximab
in a large rheumatoid arthritis population. <span><span class="ref-journal">Ann Rheum
Dis. </span>2006;<span class="ref-vol">65</span>:342–347.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1798045/">PMC free article</a>]</span> [<a href="/pubmed/16096333" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum
Dis&amp;title=The+shared+epitope+is+a+marker+of
severity+associated+with+selection+for,+but+not+with+response+to,+infliximab
in+a+large+rheumatoid+arthritis+population&amp;author=H+Marotte&amp;author=B+Pallot-Prades&amp;author=L+Grange&amp;volume=65&amp;publication_year=2006&amp;pages=342-347&amp;pmid=16096333&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b15-08_56_liu">15. <span class="element-citation">Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores
that include twenty-eight-joint counts. Development and validation in a
prospective longitudinal study of patients with rheumatoid
arthritis. <span><span class="ref-journal">Arthritis and
rheumatism. </span>1995;<span class="ref-vol">38</span>:44–48.</span> [<a href="/pubmed/7818570" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+and
rheumatism&amp;title=Modified+disease+activity+scores
that+include+twenty-eight-joint+counts.+Development+and+validation+in+a
prospective+longitudinal+study+of+patients+with+rheumatoid
arthritis&amp;author=ML+Prevoo&amp;author=MA+van+'t+Hof&amp;author=HH+Kuper&amp;author=MA+van+Leeuwen&amp;author=LB+van+de+Putte&amp;volume=38&amp;publication_year=1995&amp;pages=44-48&amp;pmid=7818570&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b16-08_56_liu">16. <span class="element-citation">van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid
arthritis improvement criteria that include simplified joint
counts. <span><span class="ref-journal">Arthritis and
rheumatism. </span>1998;<span class="ref-vol">41</span>:1845–1850.</span> [<a href="/pubmed/9778226" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+and
rheumatism&amp;title=Validation+of+rheumatoid
arthritis+improvement+criteria+that+include+simplified+joint
counts&amp;author=AM+van+Gestel&amp;author=CJ+Haagsma&amp;author=PL+van+Riel&amp;volume=41&amp;publication_year=1998&amp;pages=1845-1850&amp;pmid=9778226&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b17-08_56_liu">17. <span class="element-citation">Duerr RH, Taylor KD, Brant SR, et al.  A genome-wide association study
identifies IL23R as an inflammatory bowel disease
gene. <span><span class="ref-journal">Science. </span>2006;<span class="ref-vol">314</span>:1461–1463.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4410764/">PMC free article</a>]</span> [<a href="/pubmed/17068223" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=A+genome-wide+association+study
identifies+IL23R+as+an+inflammatory+bowel+disease
gene&amp;author=RH+Duerr&amp;author=KD+Taylor&amp;author=SR+Brant&amp;volume=314&amp;publication_year=2006&amp;pages=1461-1463&amp;pmid=17068223&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b18-08_56_liu">18. <span class="element-citation">Pe'er I, de Bakker PI, Maller J, Yelensky R, Altshuler D, Daly MJ. Evaluating and improving power in
whole-genome association studies using fixed marker
sets. <span><span class="ref-journal">Nat
Genet. </span>2006;<span class="ref-vol">38</span>:663–667.</span> [<a href="/pubmed/16715096" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat
Genet&amp;title=Evaluating+and+improving+power+in
whole-genome+association+studies+using+fixed+marker
sets&amp;author=I+Pe'er&amp;author=PI+de+Bakker&amp;author=J+Maller&amp;author=R+Yelensky&amp;author=D+Altshuler&amp;volume=38&amp;publication_year=2006&amp;pages=663-667&amp;pmid=16715096&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b19-08_56_liu">19. <span class="element-citation">Deng HW. Population admixture may appear
to mask, change or reverse genetic effects of genes underlying complex
traits. <span><span class="ref-journal">Genetics. </span>2001;<span class="ref-vol">159</span>:1319–1323.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1461858/">PMC free article</a>]</span> [<a href="/pubmed/11729172" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Population+admixture+may+appear
to+mask,+change+or+reverse+genetic+effects+of+genes+underlying+complex
traits&amp;author=HW+Deng&amp;volume=159&amp;publication_year=2001&amp;pages=1319-1323&amp;pmid=11729172&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b20-08_56_liu">20. <span class="element-citation">Seldin MF, Price AL. Application of ancestry
informative markers to association studies in European
Americans. <span><span class="ref-journal">PLoS
genetics. </span>2008;<span class="ref-vol">4</span>:e5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2211545/">PMC free article</a>]</span> [<a href="/pubmed/18208330" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS
genetics&amp;title=Application+of+ancestry
informative+markers+to+association+studies+in+European
Americans&amp;author=MF+Seldin&amp;author=AL+Price&amp;volume=4&amp;publication_year=2008&amp;pages=e5&amp;pmid=18208330&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b21-08_56_liu">21. <span class="element-citation">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis
corrects for stratification in genome-wide association
studies. <span><span class="ref-journal">Nat
Genet. </span>2006;<span class="ref-vol">38</span>:904–909.</span> [<a href="/pubmed/16862161" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat
Genet&amp;title=Principal+components+analysis
corrects+for+stratification+in+genome-wide+association
studies&amp;author=AL+Price&amp;author=NJ+Patterson&amp;author=RM+Plenge&amp;author=ME+Weinblatt&amp;author=NA+Shadick&amp;volume=38&amp;publication_year=2006&amp;pages=904-909&amp;pmid=16862161&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b22-08_56_liu">22. <span class="element-citation">Kent WJ, Sugnet CW, Furey TS, et al.  The human genome browser at
UCSC. <span><span class="ref-journal">Genome
Res. </span>2002;<span class="ref-vol">12</span>:996–1006.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC186604/">PMC free article</a>]</span> [<a href="/pubmed/12045153" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome
Res&amp;title=The+human+genome+browser+at
UCSC&amp;author=WJ+Kent&amp;author=CW+Sugnet&amp;author=TS+Furey&amp;volume=12&amp;publication_year=2002&amp;pages=996-1006&amp;pmid=12045153&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b23-08_56_liu">23. <span class="element-citation">Fisher RA. On the interpretation of
χ2 from contingency tables, and the calculation of
P. <span><span class="ref-journal">Journal of the Royal Statistical
Society. </span>1922;<span class="ref-vol">85</span>:87–94.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+the+Royal+Statistical
Society&amp;title=On+the+interpretation+of
χ2+from+contingency+tables,+and+the+calculation+of
P&amp;author=RA+Fisher&amp;volume=85&amp;publication_year=1922&amp;pages=87-94&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b24-08_56_liu">24. <span class="element-citation">Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism
in the interleukin-10 gene promoter. <span><span class="ref-journal">Eur J
Immunogenet. </span>1997;<span class="ref-vol">24</span>:1–8.</span> [<a href="/pubmed/9043871" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J
Immunogenet&amp;title=An+investigation+of+polymorphism
in+the+interleukin-10+gene+promoter&amp;author=DM+Turner&amp;author=DM+Williams&amp;author=D+Sankaran&amp;author=M+Lazarus&amp;author=PJ+Sinnott&amp;volume=24&amp;publication_year=1997&amp;pages=1-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b25-08_56_liu">25. <span class="element-citation">Kang CP, Lee KW, Yoo DH, Kang C, Bae SC. The influence of a polymorphism
at position -857 of the tumour necrosis factor alpha gene on clinical
response to etanercept therapy in rheumatoid
arthritis. <span><span class="ref-journal">Rheumatology
(Oxford) </span>2005;<span class="ref-vol">44</span>:547–552.</span> [<a href="/pubmed/15695296" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology
(Oxford)&amp;title=The+influence+of+a+polymorphism
at+position+-857+of+the+tumour+necrosis+factor+alpha+gene+on+clinical
response+to+etanercept+therapy+in+rheumatoid
arthritis&amp;author=CP+Kang&amp;author=KW+Lee&amp;author=DH+Yoo&amp;author=C+Kang&amp;author=SC+Bae&amp;volume=44&amp;publication_year=2005&amp;pages=547-552&amp;pmid=15695296&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b26-08_56_liu">26. <span class="element-citation">Criswell LA, Lum RF, Turner KN, et al.  The influence of genetic
variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment
of early rheumatoid arthritis with methotrexate or
etanercept. <span><span class="ref-journal">Arthritis and
rheumatism. </span>2004;<span class="ref-vol">50</span>:2750–2756.</span> [<a href="/pubmed/15457442" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+and
rheumatism&amp;title=The+influence+of+genetic
variation+in+the+HLA-DRB1+and+LTA-TNF+regions+on+the+response+to+treatment
of+early+rheumatoid+arthritis+with+methotrexate+or
etanercept&amp;author=LA+Criswell&amp;author=RF+Lum&amp;author=KN+Turner&amp;volume=50&amp;publication_year=2004&amp;pages=2750-2756&amp;pmid=15457442&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b27-08_56_liu">27. <span class="element-citation">Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNF alpha, LT alpha and
IL-10) polymorphisms in inflammatory bowel diseases and normal controls:
differential effects on production and allele
frequencies. <span><span class="ref-journal">Genes
Immun. </span>2000;<span class="ref-vol">1</span>:185–190.</span> [<a href="/pubmed/11196710" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes
Immun&amp;title=Cytokine+(TNF+alpha,+LT+alpha+and
IL-10)+polymorphisms+in+inflammatory+bowel+diseases+and+normal+controls:
differential+effects+on+production+and+allele
frequencies&amp;author=K+Koss&amp;author=J+Satsangi&amp;author=GC+Fanning&amp;author=KI+Welsh&amp;author=DP+Jewell&amp;volume=1&amp;publication_year=2000&amp;pages=185-190&amp;pmid=11196710&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b28-08_56_liu">28. <span class="element-citation">Yang Y, Cvekl A. Large Maf Transcription Factors:
Cousins of AP-1 Proteins and Important Regulators of Cellular
Differentiation. <span><span class="ref-journal">Einstein J Biol
Med. </span>2007;<span class="ref-vol">23</span>:2–11.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2151748/">PMC free article</a>]</span> [<a href="/pubmed/18159220" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Einstein+J+Biol
Med&amp;title=Large+Maf+Transcription+Factors:
Cousins+of+AP-1+Proteins+and+Important+Regulators+of+Cellular
Differentiation&amp;author=Y+Yang&amp;author=A+Cvekl&amp;volume=23&amp;publication_year=2007&amp;pages=2-11&amp;pmid=18159220&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b29-08_56_liu">29. <span class="element-citation">Gemelli C, Montanari M, Tenedini E, et al.  Virally mediated MafB
transduction induces the monocyte commitment of human CD34+
hematopoietic stem/progenitor cells. <span><span class="ref-journal">Cell death and
differentiation. </span>2006;<span class="ref-vol">13</span>:1686–1696.</span> [<a href="/pubmed/16456583" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+death+and
differentiation&amp;title=Virally+mediated+MafB
transduction+induces+the+monocyte+commitment+of+human+CD34+
hematopoietic+stem/progenitor+cells&amp;author=C+Gemelli&amp;author=M+Montanari&amp;author=E+Tenedini&amp;volume=13&amp;publication_year=2006&amp;pages=1686-1696&amp;pmid=16456583&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b30-08_56_liu">30. <span class="element-citation">Bakri Y, Sarrazin S, Mayer UP, et al.  Balance of MafB and PU.1
specifies alternative macrophage or dendritic cell
fate. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">105</span>:2707–2716.</span> [<a href="/pubmed/15598817" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Balance+of+MafB+and+PU.1
specifies+alternative+macrophage+or+dendritic+cell
fate&amp;author=Y+Bakri&amp;author=S+Sarrazin&amp;author=UP+Mayer&amp;volume=105&amp;publication_year=2005&amp;pages=2707-2716&amp;pmid=15598817&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b31-08_56_liu">31. <span class="element-citation">Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM. Mechanisms of disease:
proatherogenic HDL--an evolving field. <span><span class="ref-journal">Nature clinical
practice. </span>2006;<span class="ref-vol">2</span>:504–511.</span> [<a href="/pubmed/16957764" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+clinical
practice&amp;title=Mechanisms+of+disease:
proatherogenic+HDL--an+evolving+field&amp;author=M+Navab&amp;author=GM+Anantharamaiah&amp;author=ST+Reddy&amp;author=BJ+Van+Lenten&amp;author=BJ+Ansell&amp;volume=2&amp;publication_year=2006&amp;pages=504-511&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b32-08_56_liu">32. <span class="element-citation">Bodolay E, Seres I, Szodoray P, et al.  Evaluation of paraoxonase
activity in patients with mixed connective tissue
disease. <span><span class="ref-journal">The Journal of
rheumatology. </span>2008;<span class="ref-vol">35</span>:237–243.</span> [<a href="/pubmed/18085736" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of
rheumatology&amp;title=Evaluation+of+paraoxonase
activity+in+patients+with+mixed+connective+tissue
disease&amp;author=E+Bodolay&amp;author=I+Seres&amp;author=P+Szodoray&amp;volume=35&amp;publication_year=2008&amp;pages=237-243&amp;pmid=18085736&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b33-08_56_liu">33. <span class="element-citation">Kiss E, Seres I, Tarr T, Kocsis Z, Szegedi G, Paragh G. Reduced paraoxonase1 activity is
a risk for atherosclerosis in patients with systemic lupus
erythematosus. <span><span class="ref-journal">Annals of the New York Academy of
Sciences. </span>2007;<span class="ref-vol">1108</span>:83–91.</span> [<a href="/pubmed/17893973" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+the+New+York+Academy+of
Sciences&amp;title=Reduced+paraoxonase1+activity+is
a+risk+for+atherosclerosis+in+patients+with+systemic+lupus
erythematosus&amp;author=E+Kiss&amp;author=I+Seres&amp;author=T+Tarr&amp;author=Z+Kocsis&amp;author=G+Szegedi&amp;volume=1108&amp;publication_year=2007&amp;pages=83-91&amp;pmid=17893973&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b34-08_56_liu">34. <span class="element-citation">Tanimoto N, Kumon Y, Suehiro T, et al.  Serum paraoxonase activity
decreases in rheumatoid arthritis. <span><span class="ref-journal">Life
sciences. </span>2003;<span class="ref-vol">72</span>:2877–2885.</span> [<a href="/pubmed/12697270" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Life
sciences&amp;title=Serum+paraoxonase+activity
decreases+in+rheumatoid+arthritis&amp;author=N+Tanimoto&amp;author=Y+Kumon&amp;author=T+Suehiro&amp;volume=72&amp;publication_year=2003&amp;pages=2877-2885&amp;pmid=12697270&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b35-08_56_liu">35. <span class="element-citation">Batuca JR, Ames PR, Isenberg DA, Alves JD. Antibodies toward high-density
lipoprotein components inhibit paraoxonase activity in patients with
systemic lupus erythematosus. <span><span class="ref-journal">Annals of the New York
Academy of
Sciences. </span>2007;<span class="ref-vol">1108</span>:137–146.</span> [<a href="/pubmed/17893980" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+the+New+York
Academy+of
Sciences&amp;title=Antibodies+toward+high-density
lipoprotein+components+inhibit+paraoxonase+activity+in+patients+with
systemic+lupus+erythematosus&amp;author=JR+Batuca&amp;author=PR+Ames&amp;author=DA+Isenberg&amp;author=JD+Alves&amp;volume=1108&amp;publication_year=2007&amp;pages=137-146&amp;pmid=17893980&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b36-08_56_liu">36. <span class="element-citation">Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. Effects of 5'
regulatory-region polymorphisms on paraoxonasegene (PON1)
expression. <span><span class="ref-journal">American journal of human
genetics. </span>2001;<span class="ref-vol">68</span>:1428–1436.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1226129/">PMC free article</a>]</span> [<a href="/pubmed/11335891" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=American+journal+of+human
genetics&amp;title=Effects+of+5'
regulatory-region+polymorphisms+on+paraoxonasegene+(PON1)
expression&amp;author=VH+Brophy&amp;author=RL+Jampsa&amp;author=JB+Clendenning&amp;author=LA+McKinstry&amp;author=GP+Jarvik&amp;volume=68&amp;publication_year=2001&amp;pages=1428-1436&amp;pmid=11335891&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b37-08_56_liu">37. <span class="element-citation">Garin MC, James RW, Dussoix P, et al.  Paraoxonase polymorphism
Met-Leu54 is associated with modified serum concentrations of the enzyme. A
possible link between the paraoxonase gene and increased risk of
cardiovascular disease in diabetes. <span><span class="ref-journal">The Journal of
clinical
investigation. </span>1997;<span class="ref-vol">99</span>:62–66.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC507768/">PMC free article</a>]</span> [<a href="/pubmed/9011577" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of
clinical
investigation&amp;title=Paraoxonase+polymorphism
Met-Leu54+is+associated+with+modified+serum+concentrations+of+the+enzyme.+A
possible+link+between+the+paraoxonase+gene+and+increased+risk+of
cardiovascular+disease+in+diabetes&amp;author=MC+Garin&amp;author=RW+James&amp;author=P+Dussoix&amp;volume=99&amp;publication_year=1997&amp;pages=62-66&amp;pmid=9011577&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b38-08_56_liu">38. <span class="element-citation">Sanghera DK, Manzi S, Minster RL, et al.  Genetic variation in the
paraoxonase-3 (PON3) gene is associated with serum PON1
activity. <span><span class="ref-journal">Annals of human
genetics. </span>2008;<span class="ref-vol">72</span>:72–81.</span> [<a href="/pubmed/17900266" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annals+of+human
genetics&amp;title=Genetic+variation+in+the
paraoxonase-3+(PON3)+gene+is+associated+with+serum+PON1
activity&amp;author=DK+Sanghera&amp;author=S+Manzi&amp;author=RL+Minster&amp;volume=72&amp;publication_year=2008&amp;pages=72-81&amp;pmid=17900266&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b39-08_56_liu">39. <span class="element-citation">Kerekes G, Szekanecz Z, Der H, et al.  Endothelial dysfunction and
atherosclerosis in rheumatoid arthritis: a multiparametric analysis using
imaging techniques and laboratory markers of inflammation and
autoimmunity. <span><span class="ref-journal">The Journal of
rheumatology. </span>2008;<span class="ref-vol">35</span>:398–406.</span> [<a href="/pubmed/18203326" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Journal+of
rheumatology&amp;title=Endothelial+dysfunction+and
atherosclerosis+in+rheumatoid+arthritis:+a+multiparametric+analysis+using
imaging+techniques+and+laboratory+markers+of+inflammation+and
autoimmunity&amp;author=G+Kerekes&amp;author=Z+Szekanecz&amp;author=H+Der&amp;volume=35&amp;publication_year=2008&amp;pages=398-406&amp;pmid=18203326&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b40-08_56_liu">40. <span class="element-citation">Selmi C, Lleo A, Zuin M, Podda M, Rossaro L, Gershwin ME. Interferon alpha and its
contribution to autoimmunity. <span><span class="ref-journal">Curr Opin Investig
Drugs. </span>2006;<span class="ref-vol">7</span>:451–456.</span> [<a href="/pubmed/16729722" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Investig
Drugs&amp;title=Interferon+alpha+and+its
contribution+to+autoimmunity&amp;author=C+Selmi&amp;author=A+Lleo&amp;author=M+Zuin&amp;author=M+Podda&amp;author=L+Rossaro&amp;volume=7&amp;publication_year=2006&amp;pages=451-456&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b41-08_56_liu">41. <span class="element-citation">Perneger TV. What's wrong with Bonferroni
adjustments. <span><span class="ref-journal">Bmj. </span>1998;<span class="ref-vol">316</span>:1236–1238.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1112991/">PMC free article</a>]</span> [<a href="/pubmed/9553006" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bmj&amp;title=What's+wrong+with+Bonferroni
adjustments&amp;author=TV+Perneger&amp;volume=316&amp;publication_year=1998&amp;pages=1236-1238&amp;pmid=9553006&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b42-08_56_liu">42. <span class="element-citation">Sverdrup B, Kallberg H, Bengtsson C, et al.  Association between occupational
exposure to mineral oil and rheumatoid arthritis: results from the Swedish
EIRA case-control study. <span><span class="ref-journal">Arthritis research &amp;
therapy. </span>2005;<span class="ref-vol">7</span>:R1296–1303.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1297574/">PMC free article</a>]</span> [<a href="/pubmed/16277683" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+research+&amp;
therapy&amp;title=Association+between+occupational
exposure+to+mineral+oil+and+rheumatoid+arthritis:+results+from+the+Swedish
EIRA+case-control+study&amp;author=B+Sverdrup&amp;author=H+Kallberg&amp;author=C+Bengtsson&amp;volume=7&amp;publication_year=2005&amp;pages=R1296-1303&amp;pmid=16277683&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b43-08_56_liu">43. <span class="element-citation">Bokarewa M, Lindholm C, Zendjanchi K, Nadali M, Tarkowski A. Efficacy of anti-CD20 treatment
in patients with rheumatoid arthritis resistant to a combination of
methotrexate/anti-TNF therapy. <span><span class="ref-journal">Scandinavian journal of
immunology. </span>2007;<span class="ref-vol">66</span>:476–483.</span> [<a href="/pubmed/17850593" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scandinavian+journal+of
immunology&amp;title=Efficacy+of+anti-CD20+treatment
in+patients+with+rheumatoid+arthritis+resistant+to+a+combination+of
methotrexate/anti-TNF+therapy&amp;author=M+Bokarewa&amp;author=C+Lindholm&amp;author=K+Zendjanchi&amp;author=M+Nadali&amp;author=A+Tarkowski&amp;volume=66&amp;publication_year=2007&amp;pages=476-483&amp;pmid=17850593&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140677446103952title">Abstract</a></li><li><a href="#__sec1title">Introduction</a></li><li><a href="#__sec2title">Methods</a></li><li><a href="#__sec7title">Results</a></li><li><a href="#__sec11title">Discussion</a></li><li><a href="#__sec12title">Supplemental Data</a></li><li><a href="#idm140677460919616title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Molecular Medicine</span> are provided here courtesy of <strong>The Feinstein Institute for Medical Research at North Shore LIJ</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2276142/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2276142/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2276142/pdf/mol-14-9-0561.pdf">PDF (1.4M)</a></li> | <li><a href="#" data-citationid="PMC2276142" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2276142%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2276142%2F&amp;text=Genome-wide%20association%20scan%20identifies%20candidate%20polymorphisms%0Aassociated%20with%20differential%20response%20to%20anti-TNF%20treatment%20in%20Rheumatoid%0AArthritis" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2276142%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="18615156" data-aiid="2536555" data-aid="2276142" data-iid="171726" data-domainid="325" data-domain="molmed" data-accid="PMC2276142" data-md5="712676a22d953f96109529e983539f09">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-5" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input name="absid" id="absid" value="2536555" type="hidden"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" value="1" type="submit"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-6" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-6" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/20448286" ref="reftype=relart&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.</a><span class="source">[Ann Rheum Dis. 2010]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Potter C, Cordell HJ, Barton A, Daly AK, Hyrich KL, Mann DA, Morgan AW, Wilson AG, Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS)., Isaacs JD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Rheum Dis. 2010 Jul; 69(7):1315-20. Epub 2010 May 6.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/26776603" ref="reftype=relart&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis.</a><span class="source">[Arthritis Res Ther. 2016]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Honne K, Hallgrímsdóttir I, Wu C, Sebro R, Jewell NP, Sakurai T, Iwamoto M, Minota S, Jawaheer D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Arthritis Res Ther. 2016 Jan 18; 18:12. Epub 2016 Jan 18.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/20309874" ref="reftype=relart&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.</a><span class="source">[Arthritis Rheum. 2010]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cui J, Saevarsdottir S, Thomson B, Padyukov L, van der Helm-van Mil AH, Nititham J, Hughes LB, de Vries N, Raychaudhuri S, Alfredsson L, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Arthritis Rheum. 2010 Jul; 62(7):1849-61. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/28607508" ref="reftype=relart&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.</a><span class="source">[Pharmacogenomics J. 2017]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bek S, Bojesen AB, Nielsen JV, Sode J, Bank S, Vogel U, Andersen V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pharmacogenomics J. 2017 Oct; 17(5):403-411. Epub 2017 Jun 13.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/16013998" ref="reftype=relart&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis.</a><span class="source">[Pharmacogenomics. 2005]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-11" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ranganathan P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pharmacogenomics. 2005 Jul; 6(5):481-90. </em>
</div>
</li>
</ul>
<a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=18615156&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=18615156&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-12" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-12" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=books&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_books_refs&amp;IdsFromResult=2276142" ref="reftype=Cited%20in%20Books&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Books&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Cited in Books</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Cited in Books<div class="brieflinkpopdesc">PubMed Central articles cited in books</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene&amp;IdsFromResult=2276142" ref="reftype=Gene&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Gene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Gene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Gene<div class="brieflinkpopdesc">Gene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene_nucleotide&amp;IdsFromResult=2276142" ref="reftype=Gene%20(nucleotide)&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Gene (nucleotide)</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Gene (nucleotide)<div class="brieflinkpopdesc">Records in Gene identified from shared sequence links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=geoprofiles&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_geoprofiles&amp;IdsFromResult=2276142" ref="reftype=GEO%20Profiles&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">GEO Profiles</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">GEO Profiles<div class="brieflinkpopdesc">Related GEO records</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=homologene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_homologene&amp;IdsFromResult=2276142" ref="reftype=HomoloGene&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|HomoloGene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">HomoloGene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-17" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">HomoloGene<div class="brieflinkpopdesc">HomoloGene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=2276142" ref="reftype=MedGen&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-18" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=nuccore&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_nuccore&amp;IdsFromResult=2276142" ref="reftype=Nucleotide&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Nucleotide&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Nucleotide</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Nucleotide<div class="brieflinkpopdesc">Published Nucleotide sequences</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=protein&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_protein&amp;IdsFromResult=2276142" ref="reftype=Protein&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Protein&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Protein</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Protein<div class="brieflinkpopdesc">Published protein sequences</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pubmed/18615156/" ref="reftype=PubMed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-21" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=snp&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_snp&amp;IdsFromResult=2276142" ref="reftype=SNP&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|SNP&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">SNP</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-22" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">SNP<div class="brieflinkpopdesc">PMC to SNP links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=2276142" ref="reftype=Substance&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-23" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-24" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-24" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dd4023e39a66eb03df4429a">Genome-wide association scan identifies candidate polymorphisms
associated with ...</a><div class="ralinkpop offscreen_noflow">Genome-wide association scan identifies candidate polymorphisms
associated with differential response to anti-TNF treatment in Rheumatoid
Arthritis<div class="brieflinkpopdesc">Molecular Medicine. Sep-Oct 2008; 14(9-10)575</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=5dd401fe39a66eb03de7306d">Genomic Association Analysis Suggests Chromosome 12 Locus Influencing Antihypert...</a><div class="ralinkpop offscreen_noflow">Genomic Association Analysis Suggests Chromosome 12 Locus Influencing Antihypertensive Response to Thiazide Diuretic<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2008 Aug; 52(2)359</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=5dd4017b39a66eb03dc774bb">Genome-wide association defines more than thirty distinct susceptibility loci fo...</a><div class="ralinkpop offscreen_noflow">Genome-wide association defines more than thirty distinct susceptibility loci for Crohn's disease<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2008 Aug; 40(8)955</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=5dd400d0dde0893a8b3af46b">Clinical Trials and Observations: A genome-wide scan for common genetic variants...</a><div class="ralinkpop offscreen_noflow">Clinical Trials and Observations: A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose<div class="brieflinkpopdesc">Blood. 2008 Aug 15; 112(4)1022</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=5dd4009edd2142621d99be04">Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucos...</a><div class="ralinkpop offscreen_noflow">Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels
            <div class="brieflinkpopdesc">The Journal of Clinical Investigation. 2008 Jul 1; 118(7)2620</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p2" name="crb--__p2" rid="__p2" style="position: absolute; visibility: visible; width: 370px; top: 1124px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-25"><ul>
<li class="two_line" reference_id="b1-08_56_liu">
<a href="/pubmed/8717520/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Role of cytokines in rheumatoid arthritis.</a><span class="one_line_source">[Annu Rev Immunol.  1996]</span><div class="alt-note">
<div class="authors">Feldmann M, Brennan FM, Maini RN</div>
<div class="citation">Annu Rev Immunol. 1996; 14():397-440.</div>
</div>
</li>
<li class="two_line" reference_id="b3-08_56_liu">
<a href="/pubmed/3136775/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.</a><span class="one_line_source">[Arthritis Rheum.  1988]</span><div class="alt-note">
<div class="authors">Saxne T, Palladino MA Jr, Heinegård D, Talal N, Wollheim FA</div>
<div class="citation">Arthritis Rheum. 1988 Aug; 31(8):1041-5.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p3" name="crb--__p3" rid="__p3" style="position: absolute; visibility: visible; width: 370px; top: 1311px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-26"><ul>
<li class="two_line" reference_id="b4-08_56_liu">
<a href="/pubmed/11096165/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.</a><span class="one_line_source">[N Engl J Med.  2000]</span><div class="alt-note">
<div class="authors">Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK</div>
<div class="citation">N Engl J Med. 2000 Nov 30; 343(22):1586-93.</div>
</div>
</li>
<li class="two_line" reference_id="b5-08_56_liu">
<a href="/pubmed/12847678/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis.</a><span class="one_line_source">[Arthritis Rheum.  2003]</span><div class="alt-note">
<div class="authors">Mugnier B, Balandraud N, Darque A, Roudier C, Roudier J, Reviron D</div>
<div class="citation">Arthritis Rheum. 2003 Jul; 48(7):1849-52.</div>
</div>
</li>
<li class="two_line" reference_id="b6-08_56_liu">
<a href="/pubmed/15077289/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients.</a><span class="one_line_source">[Arthritis Rheum.  2004]</span><div class="alt-note">
<div class="authors">Martinez A, Salido M, Bonilla G, Pascual-Salcedo D, Fernandez-Arquero M, de Miguel S, Balsa A, de la Concha EG, Fernandez-Gutierrez B</div>
<div class="citation">Arthritis Rheum. 2004 Apr; 50(4):1077-82.</div>
</div>
</li>
<li class="two_line" reference_id="b7-08_56_liu">
<a href="/pubmed/17638513/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.</a><span class="one_line_source">[Pharmacogenomics.  2007]</span><div class="alt-note">
<div class="authors">Coenen MJ, Toonen EJ, Scheffer H, Radstake TR, Barrera P, Franke B</div>
<div class="citation">Pharmacogenomics. 2007 Jul; 8(7):761-73.</div>
</div>
</li>
<li class="two_line" reference_id="b8-08_56_liu">
<a href="/pubmed/12759288/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.</a><span class="one_line_source">[Ann Rheum Dis.  2003]</span><div class="alt-note">
<div class="authors">Padyukov L, Lampa J, Heimbürger M, Ernestam S, Cederholm T, Lundkvist I, Andersson P, Hermansson Y, Harju A, Klareskog L, Bratt J</div>
<div class="citation">Ann Rheum Dis. 2003 Jun; 62(6):526-9.</div>
</div>
</li>
<li class="two_line" reference_id="b14-08_56_liu" style="display: none;">
<a href="/pubmed/16096333/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population.</a><span class="one_line_source">[Ann Rheum Dis.  2006]</span><div class="alt-note">
<div class="authors">Marotte H, Pallot-Prades B, Grange L, Tebib J, Gaudin P, Alexandre C, Blond JL, Cazalis MA, Mougin B, Miossec P</div>
<div class="citation">Ann Rheum Dis. 2006 Mar; 65(3):342-7.</div>
</div>
</li>
<li class="two_line" reference_id="b13-08_56_liu" style="display: none;">
<a href="/pubmed/16909270/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis.</a><span class="one_line_source">[Rheumatol Int.  2006]</span><div class="alt-note">
<div class="authors">Lee YH, Rho YH, Choi SJ, Ji JD, Song GG</div>
<div class="citation">Rheumatol Int. 2006 Dec; 27(2):157-61.</div>
</div>
</li>
</ul><a href="" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p6" name="crb--__p6" rid="__p6" style="position: absolute; visibility: visible; width: 370px; top: 2002px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-27"><ul><li class="two_line" reference_id="b15-08_56_liu">
<a href="/pubmed/7818570/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.</a><span class="one_line_source">[Arthritis Rheum.  1995]</span><div class="alt-note">
<div class="authors">Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL</div>
<div class="citation">Arthritis Rheum. 1995 Jan; 38(1):44-8.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p7" name="crb--__p7" rid="__p7" style="position: absolute; visibility: visible; width: 370px; top: 2237px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-28"><ul><li class="two_line" reference_id="b16-08_56_liu">
<a href="/pubmed/9778226/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.</a><span class="one_line_source">[Arthritis Rheum.  1998]</span><div class="alt-note">
<div class="authors">van Gestel AM, Haagsma CJ, van Riel PL</div>
<div class="citation">Arthritis Rheum. 1998 Oct; 41(10):1845-50.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p8" name="crb--__p8" rid="__p8" style="position: absolute; visibility: visible; width: 370px; top: 2380px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-29"><ul>
<li class="two_line" reference_id="b17-08_56_liu">
<a href="/pubmed/17068223/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.</a><span class="one_line_source">[Science.  2006]</span><div class="alt-note">
<div class="authors">Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH</div>
<div class="citation">Science. 2006 Dec 1; 314(5804):1461-3.</div>
</div>
</li>
<li class="two_line" reference_id="b18-08_56_liu">
<a href="/pubmed/16715096/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Evaluating and improving power in whole-genome association studies using fixed marker sets.</a><span class="one_line_source">[Nat Genet.  2006]</span><div class="alt-note">
<div class="authors">Pe'er I, de Bakker PI, Maller J, Yelensky R, Altshuler D, Daly MJ</div>
<div class="citation">Nat Genet. 2006 Jun; 38(6):663-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p12" name="crb--__p12" rid="__p12" style="position: absolute; visibility: visible; width: 370px; top: 3172px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-30"><ul>
<li class="two_line" reference_id="b19-08_56_liu">
<a href="/pubmed/11729172/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Population admixture may appear to mask, change or reverse genetic effects of genes underlying complex traits.</a><span class="one_line_source">[Genetics.  2001]</span><div class="alt-note">
<div class="authors">Deng HW</div>
<div class="citation">Genetics. 2001 Nov; 159(3):1319-23.</div>
</div>
</li>
<li class="two_line" reference_id="b20-08_56_liu">
<a href="/pubmed/18208330/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Application of ancestry informative markers to association studies in European Americans.</a><span class="one_line_source">[PLoS Genet.  2008]</span><div class="alt-note">
<div class="authors">Seldin MF, Price AL</div>
<div class="citation">PLoS Genet. 2008 Jan; 4(1):e5.</div>
</div>
</li>
<li class="two_line" reference_id="b21-08_56_liu">
<a href="/pubmed/16862161/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Principal components analysis corrects for stratification in genome-wide association studies.</a><span class="one_line_source">[Nat Genet.  2006]</span><div class="alt-note">
<div class="authors">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D</div>
<div class="citation">Nat Genet. 2006 Aug; 38(8):904-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p14" name="crb--__p14" rid="__p14" style="position: absolute; visibility: visible; width: 370px; top: 3764px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul><li class="two_line" reference_id="b16-08_56_liu">
<a href="/pubmed/9778226/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.</a><span class="one_line_source">[Arthritis Rheum.  1998]</span><div class="alt-note">
<div class="authors">van Gestel AM, Haagsma CJ, van Riel PL</div>
<div class="citation">Arthritis Rheum. 1998 Oct; 41(10):1845-50.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p15" name="crb--__p15" rid="__p15" style="position: absolute; visibility: visible; width: 370px; top: 4691px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul><li class="two_line" reference_id="b22-08_56_liu">
<a href="/pubmed/12045153/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The human genome browser at UCSC.</a><span class="one_line_source">[Genome Res.  2002]</span><div class="alt-note">
<div class="authors">Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D</div>
<div class="citation">Genome Res. 2002 Jun; 12(6):996-1006.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p17" name="crb--__p17" rid="__p17" style="position: absolute; visibility: visible; width: 370px; top: 6564px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul><li class="two_line" reference_id="b16-08_56_liu">
<a href="/pubmed/9778226/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.</a><span class="one_line_source">[Arthritis Rheum.  1998]</span><div class="alt-note">
<div class="authors">van Gestel AM, Haagsma CJ, van Riel PL</div>
<div class="citation">Arthritis Rheum. 1998 Oct; 41(10):1845-50.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p18" name="crb--__p18" rid="__p18" style="position: absolute; visibility: visible; width: 370px; top: 6839px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul>
<li class="two_line" reference_id="b8-08_56_liu">
<a href="/pubmed/12759288/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.</a><span class="one_line_source">[Ann Rheum Dis.  2003]</span><div class="alt-note">
<div class="authors">Padyukov L, Lampa J, Heimbürger M, Ernestam S, Cederholm T, Lundkvist I, Andersson P, Hermansson Y, Harju A, Klareskog L, Bratt J</div>
<div class="citation">Ann Rheum Dis. 2003 Jun; 62(6):526-9.</div>
</div>
</li>
<li class="two_line" reference_id="b24-08_56_liu">
<a href="/pubmed/9043871/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">An investigation of polymorphism in the interleukin-10 gene promoter.</a><span class="one_line_source">[Eur J Immunogenet.  1997]</span><div class="alt-note">
<div class="authors">Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV</div>
<div class="citation">Eur J Immunogenet. 1997 Feb; 24(1):1-8.</div>
</div>
</li>
<li class="two_line" reference_id="b14-08_56_liu">
<a href="/pubmed/16096333/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population.</a><span class="one_line_source">[Ann Rheum Dis.  2006]</span><div class="alt-note">
<div class="authors">Marotte H, Pallot-Prades B, Grange L, Tebib J, Gaudin P, Alexandre C, Blond JL, Cazalis MA, Mougin B, Miossec P</div>
<div class="citation">Ann Rheum Dis. 2006 Mar; 65(3):342-7.</div>
</div>
</li>
<li class="two_line" reference_id="b25-08_56_liu" style="display: none;">
<a href="/pubmed/15695296/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The influence of a polymorphism at position -857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis.</a><span class="one_line_source">[Rheumatology (Oxford).  2005]</span><div class="alt-note">
<div class="authors">Kang CP, Lee KW, Yoo DH, Kang C, Bae SC</div>
<div class="citation">Rheumatology (Oxford). 2005 Apr; 44(4):547-52.</div>
</div>
</li>
<li class="two_line" reference_id="b27-08_56_liu" style="display: none;">
<a href="/pubmed/11196710/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.</a><span class="one_line_source">[Genes Immun.  2000]</span><div class="alt-note">
<div class="authors">Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP</div>
<div class="citation">Genes Immun. 2000 Feb; 1(3):185-90.</div>
</div>
</li>
<li class="two_line" reference_id="b26-08_56_liu" style="display: none;">
<a href="/pubmed/15457442/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.</a><span class="one_line_source">[Arthritis Rheum.  2004]</span><div class="alt-note">
<div class="authors">Criswell LA, Lum RF, Turner KN, Woehl B, Zhu Y, Wang J, Tiwari HK, Edberg JC, Kimberly RP, Moreland LW, Seldin MF, Bridges SL Jr</div>
<div class="citation">Arthritis Rheum. 2004 Sep; 50(9):2750-6.</div>
</div>
</li>
</ul><a href="" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p20" name="crb--__p20" rid="__p20" style="position: absolute; visibility: visible; width: 370px; top: 7123px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-35"><ul>
<li class="two_line" reference_id="b28-08_56_liu">
<a href="/pubmed/18159220/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Large Maf Transcription Factors: Cousins of AP-1 Proteins and Important Regulators of Cellular Differentiation.</a><span class="one_line_source">[Einstein J Biol Med.  2007]</span><div class="alt-note">
<div class="authors">Yang Y, Cvekl A</div>
<div class="citation">Einstein J Biol Med. 2007; 23(1):2-11.</div>
</div>
</li>
<li class="two_line" reference_id="b29-08_56_liu">
<a href="/pubmed/16456583/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells.</a><span class="one_line_source">[Cell Death Differ.  2006]</span><div class="alt-note">
<div class="authors">Gemelli C, Montanari M, Tenedini E, Zanocco Marani T, Vignudelli T, Siena M, Zini R, Salati S, Tagliafico E, Manfredini R, Grande A, Ferrari S</div>
<div class="citation">Cell Death Differ. 2006 Oct; 13(10):1686-96.</div>
</div>
</li>
<li class="two_line" reference_id="b30-08_56_liu">
<a href="/pubmed/15598817/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.</a><span class="one_line_source">[Blood.  2005]</span><div class="alt-note">
<div class="authors">Bakri Y, Sarrazin S, Mayer UP, Tillmanns S, Nerlov C, Boned A, Sieweke MH</div>
<div class="citation">Blood. 2005 Apr 1; 105(7):2707-16.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p21" name="crb--__p21" rid="__p21" style="position: absolute; visibility: visible; width: 370px; top: 7288px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-36"><ul>
<li class="two_line" reference_id="b31-08_56_liu">
<a href="/pubmed/16957764/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Mechanisms of disease: proatherogenic HDL--an evolving field.</a><span class="one_line_source">[Nat Clin Pract Endocrinol Metab.  2006]</span><div class="alt-note">
<div class="authors">Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM</div>
<div class="citation">Nat Clin Pract Endocrinol Metab. 2006 Sep; 2(9):504-11.</div>
</div>
</li>
<li class="two_line" reference_id="b32-08_56_liu">
<a href="/pubmed/18085736/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Evaluation of paraoxonase activity in patients with mixed connective tissue disease.</a><span class="one_line_source">[J Rheumatol.  2008]</span><div class="alt-note">
<div class="authors">Bodolay E, Seres I, Szodoray P, Csípo I, Jakab Z, Vegh J, Szilagyi A, Szegedi G, Paragh G</div>
<div class="citation">J Rheumatol. 2008 Feb; 35(2):237-43.</div>
</div>
</li>
<li class="two_line" reference_id="b33-08_56_liu">
<a href="/pubmed/17893973/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.</a><span class="one_line_source">[Ann N Y Acad Sci.  2007]</span><div class="alt-note">
<div class="authors">Kiss E, Seres I, Tarr T, Kocsis Z, Szegedi G, Paragh G</div>
<div class="citation">Ann N Y Acad Sci. 2007 Jun; 1108():83-91.</div>
</div>
</li>
<li class="two_line" reference_id="b34-08_56_liu" style="display: none;">
<a href="/pubmed/12697270/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Serum paraoxonase activity decreases in rheumatoid arthritis.</a><span class="one_line_source">[Life Sci.  2003]</span><div class="alt-note">
<div class="authors">Tanimoto N, Kumon Y, Suehiro T, Ohkubo S, Ikeda Y, Nishiya K, Hashimoto K</div>
<div class="citation">Life Sci. 2003 May 9; 72(25):2877-85.</div>
</div>
</li>
<li class="two_line" reference_id="b35-08_56_liu" style="display: none;">
<a href="/pubmed/17893980/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus.</a><span class="one_line_source">[Ann N Y Acad Sci.  2007]</span><div class="alt-note">
<div class="authors">Batuca JR, Ames PR, Isenberg DA, Alves JD</div>
<div class="citation">Ann N Y Acad Sci. 2007 Jun; 1108():137-46.</div>
</div>
</li>
<li class="two_line" reference_id="b36-08_56_liu" style="display: none;">
<a href="/pubmed/11335891/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.</a><span class="one_line_source">[Am J Hum Genet.  2001]</span><div class="alt-note">
<div class="authors">Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE</div>
<div class="citation">Am J Hum Genet. 2001 Jun; 68(6):1428-36.</div>
</div>
</li>
<li class="two_line" reference_id="b37-08_56_liu" style="display: none;">
<a href="/pubmed/9011577/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.</a><span class="one_line_source">[J Clin Invest.  1997]</span><div class="alt-note">
<div class="authors">Garin MC, James RW, Dussoix P, Blanché H, Passa P, Froguel P, Ruiz J</div>
<div class="citation">J Clin Invest. 1997 Jan 1; 99(1):62-6.</div>
</div>
</li>
<li class="two_line" reference_id="b38-08_56_liu" style="display: none;">
<a href="/pubmed/17900266/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity.</a><span class="one_line_source">[Ann Hum Genet.  2008]</span><div class="alt-note">
<div class="authors">Sanghera DK, Manzi S, Minster RL, Shaw P, Kao A, Bontempo F, Kamboh MI</div>
<div class="citation">Ann Hum Genet. 2008 Jan; 72(Pt 1):72-81.</div>
</div>
</li>
<li class="two_line" reference_id="b39-08_56_liu" style="display: none;">
<a href="/pubmed/18203326/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.</a><span class="one_line_source">[J Rheumatol.  2008]</span><div class="alt-note">
<div class="authors">Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipö I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P</div>
<div class="citation">J Rheumatol. 2008 Mar; 35(3):398-406.</div>
</div>
</li>
</ul><a href="" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p22" name="crb--__p22" rid="__p22" style="position: absolute; visibility: visible; width: 370px; top: 7475px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-37"><ul><li class="two_line" reference_id="b40-08_56_liu">
<a href="/pubmed/16729722/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Interferon alpha and its contribution to autoimmunity.</a><span class="one_line_source">[Curr Opin Investig Drugs.  2006]</span><div class="alt-note">
<div class="authors">Selmi C, Lleo A, Zuin M, Podda M, Rossaro L, Gershwin ME</div>
<div class="citation">Curr Opin Investig Drugs. 2006 May; 7(5):451-6.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p23" name="crb--__p23" rid="__p23" style="position: absolute; visibility: visible; width: 370px; top: 7574px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-38"><ul>
<li class="two_line" reference_id="b8-08_56_liu">
<a href="/pubmed/12759288/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.</a><span class="one_line_source">[Ann Rheum Dis.  2003]</span><div class="alt-note">
<div class="authors">Padyukov L, Lampa J, Heimbürger M, Ernestam S, Cederholm T, Lundkvist I, Andersson P, Hermansson Y, Harju A, Klareskog L, Bratt J</div>
<div class="citation">Ann Rheum Dis. 2003 Jun; 62(6):526-9.</div>
</div>
</li>
<li class="two_line" reference_id="b7-08_56_liu">
<a href="/pubmed/17638513/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.</a><span class="one_line_source">[Pharmacogenomics.  2007]</span><div class="alt-note">
<div class="authors">Coenen MJ, Toonen EJ, Scheffer H, Radstake TR, Barrera P, Franke B</div>
<div class="citation">Pharmacogenomics. 2007 Jul; 8(7):761-73.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p24" name="crb--__p24" rid="__p24" style="position: absolute; visibility: visible; width: 370px; top: 7739px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-39"><ul><li class="two_line" reference_id="b41-08_56_liu">
<a href="/pubmed/9553006/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> What's wrong with Bonferroni adjustments.</a><span class="one_line_source">[BMJ.  1998]</span><div class="alt-note">
<div class="authors">Perneger TV</div>
<div class="citation">BMJ. 1998 Apr 18; 316(7139):1236-8.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p25" name="crb--__p25" rid="__p25" style="position: absolute; visibility: visible; width: 370px; top: 8058px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-40"><ul>
<li class="two_line" reference_id="b19-08_56_liu">
<a href="/pubmed/11729172/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Population admixture may appear to mask, change or reverse genetic effects of genes underlying complex traits.</a><span class="one_line_source">[Genetics.  2001]</span><div class="alt-note">
<div class="authors">Deng HW</div>
<div class="citation">Genetics. 2001 Nov; 159(3):1319-23.</div>
</div>
</li>
<li class="two_line" reference_id="b20-08_56_liu">
<a href="/pubmed/18208330/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Application of ancestry informative markers to association studies in European Americans.</a><span class="one_line_source">[PLoS Genet.  2008]</span><div class="alt-note">
<div class="authors">Seldin MF, Price AL</div>
<div class="citation">PLoS Genet. 2008 Jan; 4(1):e5.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p26" name="crb--__p26" rid="__p26" style="position: absolute; visibility: visible; width: 370px; top: 8245px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-41"><ul>
<li class="two_line" reference_id="b7-08_56_liu">
<a href="/pubmed/17638513/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.</a><span class="one_line_source">[Pharmacogenomics.  2007]</span><div class="alt-note">
<div class="authors">Coenen MJ, Toonen EJ, Scheffer H, Radstake TR, Barrera P, Franke B</div>
<div class="citation">Pharmacogenomics. 2007 Jul; 8(7):761-73.</div>
</div>
</li>
<li class="two_line" reference_id="b42-08_56_liu">
<a href="/pubmed/16277683/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study.</a><span class="one_line_source">[Arthritis Res Ther.  2005]</span><div class="alt-note">
<div class="authors">Sverdrup B, Källberg H, Bengtsson C, Lundberg I, Padyukov L, Alfredsson L, Klareskog L, Epidemiological Investigation of Rheumatoid Arthritis Study Group.</div>
<div class="citation">Arthritis Res Ther. 2005; 7(6):R1296-303.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p27" name="crb--__p27" rid="__p27" style="position: absolute; visibility: visible; width: 370px; top: 8498px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-42"><ul><li class="two_line" reference_id="b43-08_56_liu">
<a href="/pubmed/17850593/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy.</a><span class="one_line_source">[Scand J Immunol.  2007]</span><div class="alt-note">
<div class="authors">Bokarewa M, Lindholm C, Zendjanchi K, Nadali M, Tarkowski A</div>
<div class="citation">Scand J Immunol. 2007 Oct; 66(4):476-83.</div>
</div>
</li></ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-b1-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Role of cytokines in rheumatoid arthritis.<div class="authors">Feldmann M, Brennan FM, Maini RN</div><div class="citation">Annu Rev Immunol. 1996; 14():397-440.</div><p>[<a href="/pubmed/8717520/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b1-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b3-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.<div class="authors">Saxne T, Palladino MA Jr, Heinegård D, Talal N, Wollheim FA</div><div class="citation">Arthritis Rheum. 1988 Aug; 31(8):1041-5.</div><p>[<a href="/pubmed/3136775/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b3-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b4-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.<div class="authors">Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK</div><div class="citation">N Engl J Med. 2000 Nov 30; 343(22):1586-93.</div><p>[<a href="/pubmed/11096165/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b4-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b5-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis.<div class="authors">Mugnier B, Balandraud N, Darque A, Roudier C, Roudier J, Reviron D</div><div class="citation">Arthritis Rheum. 2003 Jul; 48(7):1849-52.</div><p>[<a href="/pubmed/12847678/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b5-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b6-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients.<div class="authors">Martinez A, Salido M, Bonilla G, Pascual-Salcedo D, Fernandez-Arquero M, de Miguel S, Balsa A, de la Concha EG, Fernandez-Gutierrez B</div><div class="citation">Arthritis Rheum. 2004 Apr; 50(4):1077-82.</div><p>[<a href="/pubmed/15077289/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b6-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b7-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.<div class="authors">Coenen MJ, Toonen EJ, Scheffer H, Radstake TR, Barrera P, Franke B</div><div class="citation">Pharmacogenomics. 2007 Jul; 8(7):761-73.</div><p>[<a href="/pubmed/17638513/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b7-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b8-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.<div class="authors">Padyukov L, Lampa J, Heimbürger M, Ernestam S, Cederholm T, Lundkvist I, Andersson P, Hermansson Y, Harju A, Klareskog L, Bratt J</div><div class="citation">Ann Rheum Dis. 2003 Jun; 62(6):526-9.</div><p>[<a href="/pubmed/12759288/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b8-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b14-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population.<div class="authors">Marotte H, Pallot-Prades B, Grange L, Tebib J, Gaudin P, Alexandre C, Blond JL, Cazalis MA, Mougin B, Miossec P</div><div class="citation">Ann Rheum Dis. 2006 Mar; 65(3):342-7.</div><p>[<a href="/pubmed/16096333/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b14-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b13-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis.<div class="authors">Lee YH, Rho YH, Choi SJ, Ji JD, Song GG</div><div class="citation">Rheumatol Int. 2006 Dec; 27(2):157-61.</div><p>[<a href="/pubmed/16909270/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b13-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b15-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.<div class="authors">Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL</div><div class="citation">Arthritis Rheum. 1995 Jan; 38(1):44-8.</div><p>[<a href="/pubmed/7818570/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b15-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b16-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.<div class="authors">van Gestel AM, Haagsma CJ, van Riel PL</div><div class="citation">Arthritis Rheum. 1998 Oct; 41(10):1845-50.</div><p>[<a href="/pubmed/9778226/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b16-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b17-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.<div class="authors">Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH</div><div class="citation">Science. 2006 Dec 1; 314(5804):1461-3.</div><p>[<a href="/pubmed/17068223/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b17-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b18-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Evaluating and improving power in whole-genome association studies using fixed marker sets.<div class="authors">Pe'er I, de Bakker PI, Maller J, Yelensky R, Altshuler D, Daly MJ</div><div class="citation">Nat Genet. 2006 Jun; 38(6):663-7.</div><p>[<a href="/pubmed/16715096/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b18-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b19-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Population admixture may appear to mask, change or reverse genetic effects of genes underlying complex traits.<div class="authors">Deng HW</div><div class="citation">Genetics. 2001 Nov; 159(3):1319-23.</div><p>[<a href="/pubmed/11729172/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b19-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b20-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Application of ancestry informative markers to association studies in European Americans.<div class="authors">Seldin MF, Price AL</div><div class="citation">PLoS Genet. 2008 Jan; 4(1):e5.</div><p>[<a href="/pubmed/18208330/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b20-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b21-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Principal components analysis corrects for stratification in genome-wide association studies.<div class="authors">Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D</div><div class="citation">Nat Genet. 2006 Aug; 38(8):904-9.</div><p>[<a href="/pubmed/16862161/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b21-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b22-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The human genome browser at UCSC.<div class="authors">Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D</div><div class="citation">Genome Res. 2002 Jun; 12(6):996-1006.</div><p>[<a href="/pubmed/12045153/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b22-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b23-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">23. <span class="element-citation">Fisher RA. On the interpretation of
χ2 from contingency tables, and the calculation of
P. <span><span class="ref-journal">Journal of the Royal Statistical
Society. </span>1922;<span class="ref-vol">85</span>:87–94.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Journal+of+the+Royal+Statistical
Society&amp;title=On+the+interpretation+of
χ2+from+contingency+tables,+and+the+calculation+of
P&amp;author=RA+Fisher&amp;volume=85&amp;publication_year=1922&amp;pages=87-94&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span> [<a href="#b23-08_56_liu">Ref list</a>]</div><div id="body-link-popper-b24-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">An investigation of polymorphism in the interleukin-10 gene promoter.<div class="authors">Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV</div><div class="citation">Eur J Immunogenet. 1997 Feb; 24(1):1-8.</div><p>[<a href="/pubmed/9043871/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b24-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b25-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The influence of a polymorphism at position -857 of the tumour necrosis factor alpha gene on clinical response to etanercept therapy in rheumatoid arthritis.<div class="authors">Kang CP, Lee KW, Yoo DH, Kang C, Bae SC</div><div class="citation">Rheumatology (Oxford). 2005 Apr; 44(4):547-52.</div><p>[<a href="/pubmed/15695296/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b25-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b27-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.<div class="authors">Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP</div><div class="citation">Genes Immun. 2000 Feb; 1(3):185-90.</div><p>[<a href="/pubmed/11196710/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b27-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b26-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.<div class="authors">Criswell LA, Lum RF, Turner KN, Woehl B, Zhu Y, Wang J, Tiwari HK, Edberg JC, Kimberly RP, Moreland LW, Seldin MF, Bridges SL Jr</div><div class="citation">Arthritis Rheum. 2004 Sep; 50(9):2750-6.</div><p>[<a href="/pubmed/15457442/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b26-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b28-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Large Maf Transcription Factors: Cousins of AP-1 Proteins and Important Regulators of Cellular Differentiation.<div class="authors">Yang Y, Cvekl A</div><div class="citation">Einstein J Biol Med. 2007; 23(1):2-11.</div><p>[<a href="/pubmed/18159220/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b28-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b29-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells.<div class="authors">Gemelli C, Montanari M, Tenedini E, Zanocco Marani T, Vignudelli T, Siena M, Zini R, Salati S, Tagliafico E, Manfredini R, Grande A, Ferrari S</div><div class="citation">Cell Death Differ. 2006 Oct; 13(10):1686-96.</div><p>[<a href="/pubmed/16456583/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b29-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b30-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.<div class="authors">Bakri Y, Sarrazin S, Mayer UP, Tillmanns S, Nerlov C, Boned A, Sieweke MH</div><div class="citation">Blood. 2005 Apr 1; 105(7):2707-16.</div><p>[<a href="/pubmed/15598817/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b30-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b31-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Mechanisms of disease: proatherogenic HDL--an evolving field.<div class="authors">Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM</div><div class="citation">Nat Clin Pract Endocrinol Metab. 2006 Sep; 2(9):504-11.</div><p>[<a href="/pubmed/16957764/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b31-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b32-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Evaluation of paraoxonase activity in patients with mixed connective tissue disease.<div class="authors">Bodolay E, Seres I, Szodoray P, Csípo I, Jakab Z, Vegh J, Szilagyi A, Szegedi G, Paragh G</div><div class="citation">J Rheumatol. 2008 Feb; 35(2):237-43.</div><p>[<a href="/pubmed/18085736/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b32-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b33-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.<div class="authors">Kiss E, Seres I, Tarr T, Kocsis Z, Szegedi G, Paragh G</div><div class="citation">Ann N Y Acad Sci. 2007 Jun; 1108():83-91.</div><p>[<a href="/pubmed/17893973/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b33-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b34-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Serum paraoxonase activity decreases in rheumatoid arthritis.<div class="authors">Tanimoto N, Kumon Y, Suehiro T, Ohkubo S, Ikeda Y, Nishiya K, Hashimoto K</div><div class="citation">Life Sci. 2003 May 9; 72(25):2877-85.</div><p>[<a href="/pubmed/12697270/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b34-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b35-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus.<div class="authors">Batuca JR, Ames PR, Isenberg DA, Alves JD</div><div class="citation">Ann N Y Acad Sci. 2007 Jun; 1108():137-46.</div><p>[<a href="/pubmed/17893980/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b35-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b36-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.<div class="authors">Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE</div><div class="citation">Am J Hum Genet. 2001 Jun; 68(6):1428-36.</div><p>[<a href="/pubmed/11335891/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b36-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b37-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.<div class="authors">Garin MC, James RW, Dussoix P, Blanché H, Passa P, Froguel P, Ruiz J</div><div class="citation">J Clin Invest. 1997 Jan 1; 99(1):62-6.</div><p>[<a href="/pubmed/9011577/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b37-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b38-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity.<div class="authors">Sanghera DK, Manzi S, Minster RL, Shaw P, Kao A, Bontempo F, Kamboh MI</div><div class="citation">Ann Hum Genet. 2008 Jan; 72(Pt 1):72-81.</div><p>[<a href="/pubmed/17900266/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b38-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b39-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.<div class="authors">Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipö I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P</div><div class="citation">J Rheumatol. 2008 Mar; 35(3):398-406.</div><p>[<a href="/pubmed/18203326/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b39-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b40-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Interferon alpha and its contribution to autoimmunity.<div class="authors">Selmi C, Lleo A, Zuin M, Podda M, Rossaro L, Gershwin ME</div><div class="citation">Curr Opin Investig Drugs. 2006 May; 7(5):451-6.</div><p>[<a href="/pubmed/16729722/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b40-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b41-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> What's wrong with Bonferroni adjustments.<div class="authors">Perneger TV</div><div class="citation">BMJ. 1998 Apr 18; 316(7139):1236-8.</div><p>[<a href="/pubmed/9553006/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b41-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b42-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study.<div class="authors">Sverdrup B, Källberg H, Bengtsson C, Lundberg I, Padyukov L, Alfredsson L, Klareskog L, Epidemiological Investigation of Rheumatoid Arthritis Study Group.</div><div class="citation">Arthritis Res Ther. 2005; 7(6):R1296-303.</div><p>[<a href="/pubmed/16277683/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b42-08_56_liu">Ref list</a>]</p></div><div id="body-link-popper-b43-08_56_liu" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy.<div class="authors">Bokarewa M, Lindholm C, Zendjanchi K, Nadali M, Tarkowski A</div><div class="citation">Scand J Immunol. 2007 Oct; 66(4):476-83.</div><p>[<a href="/pubmed/17850593/" ref="reftype=pubmed&amp;article-id=2276142&amp;issue-id=171726&amp;journal-id=325&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b43-08_56_liu">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-19T09:54:54-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE89FE20DD3FA0910000000006EB0428&amp;ncbi_session=CE8B7BC8DD3EA361_1439SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2276142%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=molmed&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2276142/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B7BC8DD3EA361_1439SID /projects/PMC/PMCViewer@4.46 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div><div style="position: absolute; width: 0px; height: 0px; overflow: hidden; padding: 0px; border: 0px none; margin: 0px;"><div id="MathJax_Font_Test" style="position: absolute; visibility: hidden; top: 0px; left: 0px; width: auto; padding: 0px; border: 0px none; margin: 0px; white-space: nowrap; text-align: left; text-indent: 0px; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; font-size: 40px; font-weight: normal; font-style: normal; font-size-adjust: none; font-family: MathJax_Size3, sans-serif;"></div></div></body></html>